UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June 30, 2023~~March 31, 2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number: 001-37763

TURNING POINT BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware		20-0709285
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification No.)

5201 Interchange Way, Louisville, KY		40229
(Address of principal executive offices)		(Zip Code)

(502) 778-4421

(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: not applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	TPB	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☑
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

At ~~July~~April 26, ~~2023,~~2024, there were ~~17,595,579~~17,621,706 shares outstanding of the registrant’s voting common stock, par value $0.01 per share.

TURNING POINT BRANDS, INC.

TABLE OF CONTENTS

			Page No.
PART I—FINANCIAL INFORMATION

	ITEM 1	Financial Statements (Unaudited)

		Consolidated Balance Sheets as of ~~June 30, 2023,~~March 31, 2024, and December 31, ~~2022~~2023	6

		~~Consolidated Statements of Income for the three months ended June 30, 2023 and 2022~~	7

		~~Consolidated Statements of Income for the six months ended June 30, 2023 and 2022~~	8

		~~Consolidated Statements of Comprehensive Income for the three months ended June 30, 2023 and 2022~~	9

		~~Consolidated Statements of Comprehensive Income for the six months ended June 30, 2023 and 2022~~	9

		~~Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022~~	10

		~~Consolidated Statements of Changes in Stockholders’ Equity for the three months ended June 30, 2023 and 2022~~	115

		Consolidated Statements of Income for the three months ended March 31, 2024 and 2023	6

		Consolidated Statements of Comprehensive Income for the three months ended March 31, 2024 and 2023	7

		Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023	8

		Consolidated Statements of Changes in Stockholders’ Equity for the ~~six~~three months ended ~~June 30,~~March 31, 2024 and 2023 ~~and 2022~~	119

		Notes to Consolidated Financial Statements	1210

	ITEM 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3530

	ITEM 3	Quantitative and Qualitative Disclosures about Market Risk	4638

	ITEM 4	Controls and Procedures	4639

PART II—OTHER INFORMATION

	ITEM 1	Legal Proceedings	4740

	ITEM 1A	Risk Factors	4740

	ITEM 2	Unregistered Sales of Equity Securities and Use of Proceeds	4840

	ITEM 3	Defaults Upon Senior Securities	4840

	ITEM 4	Mine Safety Disclosures	4840

	ITEM 5	Other Information	4840

	ITEM 6	Exhibits	49 41

	Signatures		5042

Table of Contents

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (this “Quarterly Report”), contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. (“TPB”), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to:

●

declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall;

●

our dependence on a small number of third-party suppliers and producers;

●

the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost;

●

the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;

●

failure to maintain consumer brand recognition and loyalty of our customers;

●

our reliance on relationships with several large retailers and national chains for distribution of our products;

●

intense competition and our ability to compete effectively;

●

competition from illicit sources and the damage caused by illicit products to our brand equity;

●

contamination of our tobacco supply or products;

●

uncertainty and continued evolution of the markets for our ~~Creative Distribution Solutions~~ products;

●

complications with the design or implementation of our new enterprise resource planning system could adversely impact our business and operations;

●

substantial and increasing regulation and changes in U.S. ~~regulation;~~Food and Drug Administration (“FDA”) enforcement priorities;

●

regulation or marketing denials of our products by the ~~U.S. Food and Drug Administration,~~FDA, which has broad regulatory powers;

●

many of our products contain nicotine, which is considered to be a highly addictive substance;

●

requirement to maintain compliance with master settlement agreement escrow ~~account~~;

account;

●

possible significant increases in federal, state and local municipal tobacco- and ~~vapor-related~~nicotine-related taxes;

●

our products are marketed pursuant to a policy of FDA enforcement priorities which could change, and our products could become subject to increased regulatory burdens by the FDA;

●

our products are subject to developing and unpredictable regulation, such as court actions that impact obligations;

●

increase in state and local regulation of our ~~Creative Distribution Solutions~~ products has been proposed or enacted;

●

increase in tax of our ~~Creative Distribution Solutions~~ products could adversely affect our business;

●

sensitivity of end-customers to increased sales taxes and economic conditions, including ~~significant increases in the rate~~as a result of inflation and other declines in purchasing power;

●

~~uncertainty surrounding FDA compliance policy;~~

●

possible increasing international control and regulation;

●

failure to comply with environmental, health and safety regulations;

●

imposition of significant tariffs on imports into the U.S.;

●

the scientific community’s lack of information regarding the long-term health effects of certain substances contained in some of our products;

●

significant product liability litigation;

●

our amount of indebtedness;

●

the terms of our indebtedness, which may restrict our current and future operations;

●

our ability to ~~comply with required disclosure requirements;~~establish and maintain effective internal controls over financial reporting;

●

our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors. These restrictions may affect the liquidity of our common stock and may result in Restricted Investors (as defined in our Certificate of Incorporation) being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights;

~~Table of Contents~~

●

future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us;

Table of Contents

●

we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock;

●

our business may be damaged by events outside of our suppliers’ control, such as the impact of epidemics (e.g., coronavirus), political upheavals, or natural disasters;

●

adverse impact of climate change;

●

our reliance on information technology;

●

cybersecurity and privacy ~~breaches;~~breaches, which have increased in part due to artificial intelligence;

●

failure to manage our growth;

●

failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;

●

fluctuations in our results;

●

exchange rate fluctuations;

●

adverse U.S. and global economic conditions;

●

departure of key management personnel or our inability to attract and retain talent;

●

infringement on or misappropriation of our intellectual property;

●

third-party claims that we infringe on their intellectual property; and

●

failure to meet expectations relating to environmental, social and governance factors.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Turning Point Brands, Inc.

~~Consolidated~~ Consolidated Balance Sheets

(dollars in thousands except share data)

	(unaudited)						(unaudited)
	June 30,			December 31,			March 31,			December 31,
ASSETS	2023			2022			2024			2023
Current assets:
Cash	$	100,507		$	106,403		$	130,903		$	117,886
Accounts receivable, net of allowances of $103 in 2023 and $114 in 2022		7,920			8,377
Inventories		125,056			119,915
Accounts receivable, net of allowances of $43 in 2024 and $78 in 2023								8,198			9,989
Inventories, net								105,467			98,960
Other current assets		18,216			22,959			34,437			40,781
Total current assets		251,699			257,654			279,005			267,616
Property, plant, and equipment, net		24,128			22,788			24,790			25,300
Deferred income taxes		7,966			8,443			1,426			1,468
Right of use assets		10,923			12,465			10,868			11,480
Deferred financing costs, net		229			282			2,305			2,450
Goodwill		136,244			136,253			136,365			136,250
Other intangible assets, net		82,048			83,592			80,177			80,942
Master Settlement Agreement (MSA) escrow deposits		28,229			27,980			28,427			28,684
Other assets		18,208			22,649			22,953			15,166
Total assets	$	559,674		$	572,106		$	586,316		$	569,356

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	10,802		$	8,355		$	18,934		$	8,407
Accrued liabilities		30,898			33,001			30,974			33,635
Other current liabilities		5			20
Current portion of long-term debt								59,397			58,294
Total current liabilities		41,705			41,376			109,305			100,336
Notes payable and long-term debt		379,195			406,757			306,496			307,064
Lease liabilities		9,528			10,593			9,360			9,950
Total liabilities		430,428			458,726			425,161			417,350

Commitments and contingencies

Stockholders’ equity:
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-		-			-			–			–
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 19,912,039 issued shares and 17,595,579 outstanding shares at June 30, 2023, and 19,801,623 issued shares and 17,485,163 outstanding shares at December 31, 2022		199			198
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 20,016,822 issued shares and 17,627,817 outstanding shares at March 31, 2024, and 19,922,137 issued shares and 17,605,677 outstanding shares at December 31, 2023								200			199
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-		-			-			–			–
Additional paid-in capital		115,272			113,242			119,792			119,075
Cost of repurchased common stock (2,316,460 shares at June 30, 2023 and December 31, 2022)		(78,093	)		(78,093	)
Cost of repurchased common stock (2,389,005 shares at March 31, 2024 and 2,316,460 shares December 31, 2023)								(80,172	)		(78,093	)
Accumulated other comprehensive loss		(3,181	)		(2,393	)		(3,048	)		(2,648	)
Accumulated earnings		93,873			78,691			123,192			112,443
Non-controlling interest		1,176			1,735			1,191			1,030
Total stockholders’ equity		129,246			113,380			161,155			152,006
Total liabilities and stockholders’ equity	$	559,674		$	572,106		$	586,316		$	569,356

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated ~~Consolidated~~ Statements of Income

(dollars in thousands except share and per share data)

(unaudited)

	Three Months Ended March 31,
	2024			2023
Net sales	$	97,058		$	100,956
Cost of sales		45,146			52,339
Gross profit		51,912			48,617
Selling, general, and administrative expenses		32,646			30,775
Operating income		19,266			17,842
Interest expense, net		3,479			4,010
Investment (gain) loss		(119	)		4,799
Gain on extinguishment of debt		–			(777	)
Income before income taxes		15,906			9,810
Income tax expense		3,727			2,468
Consolidated net income		12,179			7,342
Net income (loss) attributable to non-controlling interest		169			(255	)
Net income attributable to Turning Point Brands, Inc.	$	12,010		$	7,597

Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.68		$	0.43
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.63		$	0.41
Weighted average common shares outstanding:
Basic		17,654,684			17,531,414
Diluted		20,170,314			20,669,152

Three Months Ended
June 30,

2023 2022

Net sales $ 105,595 $ 102,925
Cost of sales 53,117 51,456
Gross profit 52,478 51,469
Selling, general, and administrative expenses 31,933 33,323
Operating income 20,545 18,146
Interest expense, net 4,019 5,144
Investment loss
4,080 6,227
Gain on extinguishment of debt (600 ) -
Income before income taxes 13,046 6,775
Income tax expense 3,338 1,569
Consolidated net income 9,708 5,206
Net loss attributable to non-controlling interest (217 ) (218 )
Net income attributable to Turning Point Brands, Inc. $ 9,925 $ 5,424

Basic income per common share:
Net income attributable to Turning Point Brands, Inc. $ 0.56 $ 0.30
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc. $ 0.53 $ 0.30
Weighted average common shares outstanding:
Basic 17,584,241 18,063,259
Diluted 20,409,943 21,443,279

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Comprehensive Income

(dollars in thousands)

(unaudited)

	Three Months Ended March 31,
	2024			2023
Consolidated net income	$	12,179		$	7,342

Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax of $15 in 2024 and $176 in 2023		(242	)		553
Foreign currency translation, net of tax of $0 in 2024 and 2023		13			(78	)
Unrealized loss on derivative instruments, net of tax of $57 in 2024 and $109 in 2023		(185	)		(344	)
Unrealized gain on investments, net of tax of $0 in 2024		6			–
		(408	)		131
Consolidated comprehensive income		11,771			7,473
Comprehensive income (loss) attributable to non-controlling interest		169			(255	)
Comprehensive income attributable to Turning Point Brands, Inc.	$	11,602		$	7,728

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of ~~Income~~Cash Flows

(dollars in ~~thousands except share data)~~thousands)

(unaudited)

Six Months Ended
June 30,

2023 2022

Net sales $ 206,551 $ 203,819
Cost of sales 105,456 100,556
Gross profit 101,095 103,263
Selling, general, and administrative expenses 62,708 65,888
Operating income 38,387 37,375
Interest expense, net 8,029 10,340
Investment loss
8,879 6,149
Gain on extinguishment of debt (1,377 ) -
Income before income taxes 22,856 20,886
Income tax expense 5,806 4,909
Consolidated net income 17,050 15,977
Net loss attributable to non-controlling interest (472 ) (445 )
Net income attributable to Turning Point Brands, Inc. $ 17,522 $ 16,422

Basic income per common share:
Net income attributable to Turning Point Brands, Inc. $ 1.00 $ 0.90
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc. $ 0.94 $ 0.86
Weighted average common shares outstanding:
Basic 17,556,030 18,159,940
Diluted 20,538,947 21,603,113

	Three Months Ended March 31,
	2024			2023
Cash flows from operating activities:
Consolidated net income	$	12,179		$	7,342
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on extinguishment of debt		–			(777	)
Loss (gain) on sale of property, plant, and equipment		1			(6	)
Gain on MSA investments		6			–
Depreciation and other amortization expense		944			776
Amortization of other intangible assets		779			771
Amortization of deferred financing costs		696			626
Deferred income tax expense (benefit)		114			299
Stock compensation expense		2,062			743
Noncash lease income		(42	)		(14	)
Loss on investments		–			4,897
Changes in operating assets and liabilities:
Accounts receivable		1,929			(216	)
Inventories		(6,296	)		6,173
Other current assets		3,130			2,639
Other assets		(270	)		(2,895	)
Accounts payable		10,525			2,051
Accrued liabilities and other		(3,118	)		(7,025	)
Net cash provided by operating activities	$	22,639		$	15,384

Cash flows from investing activities:
Capital expenditures	$	(366	)	$	(2,435	)
Purchases of investments		(7,119	)		–
Purchases of non-marketable equity investments		(500	)		–
Proceeds on sale of property, plan and equipment		–			3
Restricted cash, MSA escrow deposits		(1	)		–
Net cash used in investing activities	$	(7,986	)	$	(2,432	)

Cash flows from financing activities:
Convertible Senior Notes repurchased	$	–		$	(13,002	)
Proceeds from call options		–			33
Payment of dividends		(1,149	)		(1,052	)
Exercise of options		3			357
Redemption of restricted stock units		(136	)		–
Redemption of performance restricted stock units		(1,212	)		(889	)
Common stock repurchased		(2,079	)		–
Net cash used in financing activities	$	(4,573	)	$	(14,553	)

Net increase (decrease) in cash	$	10,080		$	(1,601	)
Effect of foreign currency translation on cash	$	(58	)	$	(1	)

Cash, beginning of period:
Unrestricted	$	117,886		$	106,403
Restricted		4,929			4,929
Total cash at beginning of period	$	122,815		$	111,332

Cash, end of period:
Unrestricted	$	130,903		$	104,801
Restricted		1,934			4,929
Total cash at end of period	$	132,837		$	109,730

Supplemental schedule of noncash investing activities:
Accrued capital expenditures	$	10		$	7

Supplemental schedule of noncash financing activities:
Dividends declared not paid	$	1,261		$	1,155

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of ~~Comprehensive Income~~Changes in Stockholders’ Equity

For the Three Months Ended March 31, 2024 and 2023

(dollars in ~~thousands)~~

thousands except share data)

(unaudited)

									Cost of			Accumulated
				Common		Additional			Repurchased			Other						Non-
	Voting			Stock,		Paid-In			Common			Comprehensive			Accumulated			Controlling
	Shares			Voting		Capital			Stock			Income (Loss)			Earnings			Interest			Total
Beginning balance January 1, 2024		17,605,677		$	199	$	119,075		$	(78,093	)	$	(2,648	)	$	112,443		$	1,030		$	152,006

Unrealized loss on MSA investments, net of tax of $15		–			–		–			–			(242	)		–			–			(242	)
Unrealized loss on derivative instruments, net of tax of $57		–			–		–			–			(185	)		–			–			(185	)
Foreign currency translation, net of tax of $0		–			–		–			–			21			–			(8	)		13
Unrealized gain on investments, net of tax of $0		–			–		–			–			6			–			–			6
Stock compensation expense		–			–		2,062			–			–			–			–			2,062
Exercise of options		198			–		3			–			–			–			–			3
Cost of repurchased common stock		(72,545	)		–		–			(2,079	)		–			–			–			(2,079	)
Issuance of performance based restricted stock units		126,109			1		–			–			–			–			–			1
Issuance of restricted stock units		21,697			–		–			–			–			–			–			–
Redemption of performance based restricted stock units		(48,177	)		–		(1,212	)		–			–			–			–			(1,212	)
Redemption of restricted stock units		(5,142	)		–		(136	)		–			–			–			–			(136	)
Dividends		–			–		–			–			–			(1,261	)		–			(1,261	)
Net income		–			–		–			–			–			12,010			169			12,179
Ending balance March 31, 2024		17,627,817		$	200	$	119,792		$	(80,172	)	$	(3,048	)	$	123,192		$	1,191		$	161,155


Beginning balance January 1, 2023		17,485,163		$	198	$	113,242		$	(78,093	)	$	(2,393	)	$	78,691		$	1,735		$	113,380

Unrealized gain on MSA investments, net of tax of $176		–			–		–			–			553			–			–			553
Unrealized loss on derivative instruments, net of tax of $109		–			–		–			–			(344	)		–			–			(344	)
Foreign currency translation, net of tax of $0		–			–		–			–			(50	)		–			(28	)		(78	)
Stock compensation expense		–			–		743			–			–			–			–			743
Exercise of options		24,955			–		357			–			–			–			–			357
Performance restricted stock units issuance		114,274			1		(1	)		–			–			–			–			–
Performance restricted stock units redeemed		(38,863	)		–		(889	)		–			–			–			–			(889	)
Settlement of call options, net of tax of $8		–			–		25			–			–			-			-			25
Dividends		–			–		–			–			–			(1,155	)		–			(1,155	)
Net income		–			–		–			–			–			7,597			(255	)		7,342
Ending balance March 31, 2023		17,585,529		$	199	$	113,477		$	(78,093	)	$	(2,234	)	$	85,133		$	1,452		$	119,934

Three Months Ended
June 30,

2023 2022
Consolidated net income $ 9,708 $ 5,206

Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax of $116 in 2023 and $244 in 2022
(365 ) (768 )
Foreign currency translation, net of tax of $0 in 2023 and 2022
(169 ) 45
Unrealized loss on derivative instruments, net of tax of $150 in 2023 and $0 in 2022
(472 ) -
(1,006 ) (723 )
Consolidated comprehensive income 8,702 4,483
Comprehensive loss attributable to non-controlling interest (217 ) (203 )
Comprehensive income attributable to Turning Point Brands, Inc. $ 8,919 $ 4,686

Six Months Ended
June 30,

2023 2022
Consolidated net income $ 17,050 $ 15,977

Other comprehensive income (loss), net of tax
Unrealized gain (loss) on MSA investments, net of tax of $60 in 2023 and $602 in 2022
188 (1,894 )
Foreign currency translation, net of tax of $0 in 2023 and 2022
(248 ) 38
Unrealized loss on derivative instruments, net of tax of $259 in 2023 and $0 in 2022
(815 ) -
(875 ) (1,856 )
Consolidated comprehensive income 16,175 14,121
Comprehensive loss attributable to non-controlling interest (472 ) (432 )
Comprehensive income attributable to Turning Point Brands, Inc. $ 16,647 $ 14,553

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

~~Turning Point Brands, Inc.~~

~~Consolidated Statements of~~ ~~Cash Flows~~

~~(dollars in thousands)~~

~~(unaudited)~~

Six Months Ended
June 30,

2023 2022
Cash flows from operating activities:
Consolidated net income $ 17,050 $ 15,977
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on extinguishment of debt
(1,377 ) -
Loss (gain) on sale of property, plant, and equipment
44 (8 )
Depreciation expense 1,535 1,750
Amortization of other intangible assets 1,542 919
Amortization of deferred financing costs 1,225 1,291
Deferred income tax expense (benefit) 659 (146 )
Stock compensation expense 2,836 2,661
Noncash lease income
(29 ) (6 )
Loss on investments
8,989 6,258
Changes in operating assets and liabilities:
Accounts receivable 456 (2,673 )
Inventories (5,146 ) (27,499 )
Other current assets 3,769 (598 )
Other assets (4,548 ) 624
Accounts payable 2,500 7,240
Accrued liabilities and other (1,972 ) 1,359
Net cash provided by operating activities $ 27,533 $ 7,149

Cash flows from investing activities:
Capital expenditures $ (2,993 ) $ (5,694 )
Restricted cash, MSA escrow deposits $ - $ (10,078 )
Proceeds on the sale of property, plant and equipment 3 63
Net cash used in investing activities $ (2,990 ) $ (15,709 )

Cash flows from financing activities:
Convertible Senior Notes repurchased
$ (27,357 ) $ -
Proceeds from call options 70 -
Payment of dividends (2,209 ) (2,181 )
Exercise of options 406 475
Redemption of options
(346 ) (155 )
Redemption of performance restricted stock units
(995 ) (1,228 )
Common stock repurchased - (19,418 )
Net cash used in financing activities
$ (30,431 ) $ (22,507 )

Net decrease in cash
$ (5,888 ) $ (31,067 )
Effect of foreign currency translation on cash $ (8 ) $ 56

Cash, beginning of period:
Unrestricted 106,403 128,320
Restricted 4,929 15,155
Total cash at beginning of period 111,332 143,475

Cash, end of period:
Unrestricted 100,507 107,429
Restricted 4,929 5,035
Total cash at end of period $ 105,436 $ 112,464

Supplemental schedule of noncash investing activities:
Accrued capital expenditures $ 42 $ 19

Supplemental schedule of noncash financing activities:
Dividends declared not paid $ 1,188 $ 1,110

~~The accompanying notes are an integral part of the consolidated financial statements.~~

~~Table of Contents~~

~~Turning Point Brands, Inc.~~

~~Consolidated Statements of Changes in Stockholders’ Equity~~

~~For the Three and Six Months Ended June 30, 2023 and 2022~~

~~(dollars in thousands except share data)~~

~~(unaudited)~~

Accumulated
Common Additional Cost of
Other Non-
Voting Stock, Paid-In Repurchased
Comprehensive Accumulated Controlling

Shares Voting Capital Common Stock Income (Loss) Earnings
Interest Total

Beginning balance April 1, 2023
17,585,529 $ 199 $ 113,477 $ (78,093 ) $ (2,234 ) $ 85,133 $ 1,452 $ 119,934

Unrealized loss on MSA investments, net of tax of $116
- - - - (365 ) - - (365 )
Unrealized loss on derivative instruments, net of tax of $150 - - - - (472 ) - - (472 )
Foreign currency translation, net of tax of $0
- - - - (110 ) - (59 ) (169 )
Stock compensation expense - - 2,093 - - - - 2,093
Exercise of options 4,416 - 49 - - - - 49
Redemption of options
(15,985 ) - (346 ) - - - - (346 )
Performance restricted stock units issuance
26,050 - 78 - - - - 78
Performance restricted stock units redeemed
(4,431 ) - (105 ) - - - - (105 )
Settlement of call options, net of tax of $9
- - 26 - - - - 26
Dividends - - - - - (1,185 ) - (1,185 )
Net income - - - - - 9,925 (217 ) 9,708
Ending balance June 30, 2023
17,595,579 $ 199 $ 115,272 $ (78,093 ) $ (3,181 ) $ 93,873 $ 1,176 $ 129,246

Beginning balance April 1, 2022
18,180,174 $ 198 $ 109,073 $ (59,491 ) $ (1,326 ) $ 81,327 $ 2,083 $ 131,864

Unrealized loss on MSA investments, net of tax of $244
- - - - (768 ) - - (768 )
Foreign currency translation, net of tax of $0
- - - - 30 - 15 45
Stock compensation expense - - 1,502 - - - - 1,502
Exercise of options 7,175 - 230 - - - - 230
Redemption of options
- - (155 ) - - - - (155 )
Performance restricted stock units issuance
4,754 - - - - - - -
Performance restricted stock units redeemed
- - (87 ) - - - - (87 )
Cost of repurchased common stock (301,662 ) - - (8,796 ) - - - (8,796 )
Dividends - - - - - (1,110 ) - (1,110 )
Net income - - - - - 5,424 (218 ) 5,206
Ending balance June 30, 2022
17,890,441 $ 198 $ 110,563 $ (68,287 ) $ (2,064 ) $ 85,641 $ 1,880 $ 127,931

Accumulated
Common Additional
Cost of
Other Non-
Voting Stock, Paid-In Repurchased
Comprehensive Accumulated Controlling

Shares Voting Capital Common Stock Income (Loss) Earnings
Interest Total
Beginning balance January 1, 2023
17,485,163 $ 198 $ 113,242 $ (78,093 ) $ (2,393 ) $ 78,691 $ 1,735 $ 113,380

Unrealized gain on MSA investments, net of tax of $60
- - - - 188 - - 188
Unrealized loss on derivative instruments, net of tax of $259 - - - - (815 ) - - (815 )
Foreign currency translation, net of tax of $0
- - - - (161 ) - (87 ) (248 )
Stock compensation expense - - 2,836 - - - - 2,836
Exercise of options 29,371 - 406 - - - - 406
Redemption of options
(15,985 ) - (346 ) - - - - (346 )
Performance restricted stock units issuance

140,324
1 77 - - - - 78
Performance restricted stock units redeemed
(43,294 ) - (995 ) - - - - (995 )
Settlement of call options, net of tax of $17
- - 52 - - - - 52
Dividends - - - - - (2,340 ) - (2,340 )
Net income - - - - - 17,522 (472 ) 17,050
Ending balance June 30, 2023
17,595,579 $ 199 $ 115,272 $ (78,093 ) $ (3,181 ) $ 93,873 $ 1,176 $ 129,246

Beginning balance January 1, 2022
18,395,476 $ 197 $ 108,811 $ (48,869 ) $ (195 ) $ 71,460 $ 2,312 $ 133,716

Unrealized loss on MSA investments, net of tax of $602
- - - - (1,894 ) - - (1,894 )
Foreign currency translation, net of tax of $0
- - - - 25 - 13 38
Stock compensation expense - - 2,661 - - - - 2,661
Exercise of options 32,341 - 475 - - - - 475
Redemption of options
- - (155 ) - - - - (155 )
Performance restricted stock units issuance
74,510 1 (1 ) - - - - -
Performance restricted stock units redeemed
- - (1,141 ) - - - - (1,141 )
Redemption of restricted stock units
- - (87 ) - - - - (87 )
Cost of repurchased common stock (611,886 ) - - (19,418 ) - - - (19,418 )
Dividends - - - - - (2,241 ) - (2,241 )
Net income - - - - - 16,422 (445 ) 15,977
Ending balance June 30, 2022
17,890,441 $ 198 $ 110,563 $ (68,287 ) $ (2,064 ) $ 85,641 $ 1,880 $ 127,931

~~The accompanying notes are an integral part of the consolidated financial statements.~~

~~Table of Contents~~

Turning Point Brands, Inc.

Notes to to Consolidated Financial Statements

(dollars in thousands, except where designated and per share data)

Note 1. Description of Business and Basis of Presentation

Description of Business

Turning Point Brands, Inc. and its subsidiaries (collectively referred to herein as the “Company,” “we,” “our,” or “us”) is a leading manufacturer, marketer and distributor of branded consumer products. The Company sells a wide range of products to adult consumers consisting of staple products with its iconic brands Zig-Zag^®and Stoker’s^®and its next generation products to fulfill evolving consumer preferences. Its segments are led by its core proprietary and iconic brands: Zig-Zag^® and CLIPPER^® in the Zig-Zag Products ~~segment;~~segment and Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment. The Company’s products are available in more than 217,000 retail outlets in North America. The Company operates in three segments: (i) Zig-Zag Products, (ii) Stoker’s Products, and (iii) Creative Distribution Solutions (formerly known as NewGen).

Basis of Presentation

The accompanying unaudited, interim, consolidated financial statements have been prepared in accordance with the accounting practices described in the Company’s audited, consolidated financial statements as of and for the year ended December 31, ~~2022.~~2023. In the opinion of management, the unaudited, interim, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods ~~indicated.~~presented. Such adjustments, other than nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, ~~2022.~~2023. The accompanying interim, consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the United States (“GAAP”) with respect to annual financial statements.

Note 2. Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries, all of which are wholly-owned, and variable interest entities ~~(“VIEs”)~~ for which the Company is considered the primary beneficiary. All significant intercompany transactions have been eliminated.

Revenue Recognition

The Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606), which includes excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns and incentives, upon delivery of goods to the customer – at which time the Company’s performance obligation is satisfied - at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. The Company excludes from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on smokeless tobacco, cigars or ~~vaping~~other nicotine products billed to customers).

The Company records an allowance for sales returns, based principally on historical volume and return rates, which is included in accrued liabilities on the consolidated balance sheets. The Company records sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction in revenues (a portion of which is based on amounts estimated to be due to wholesalers, retailers and consumers at the end of the period) based principally on historical volume and utilization rates. Expected payments for sales incentives are included in accrued liabilities on the consolidated balance sheets.

1210

Table of Contents

A further requirement of ASC 606 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company’s management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16, “Segment Information”. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.

Shipping Costs

The Company records shipping costs incurred as a component of selling, general, and administrative expenses. Shipping costs incurred were approximately ~~$5.7~~$5.6 million and ~~$6.0~~$6.2 million for the three months ending March~~June 30~~ 31, 2024 and 2023, ~~and 2022, respectively.~~ ~~Shipping costs incurred were approximately $11.9 million and $12.1 million for the six months ending June 30, 2023 and 2022,~~ respectively.

Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out ~~(“FIFO”)~~ method. Leaf tobacco is presented in current assets in accordance with standard industry practice, notwithstanding the fact that such tobaccos are carried longer than one year for the purpose of curing.

Fair Value

GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

The three levels of the fair value hierarchy under GAAP are described below:

●

Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.

●

Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

●

Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

Derivative Instruments

The Company enters into foreign currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging. Under the Company’s policy, the Company may hedge up to 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed twelve months. The Company may also, from time to time, hedge up to 100% of its non-inventory purchases (e.g., production equipment) in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are reclassified from other comprehensive income into inventory as the related inventories are received and are transferred to net income as inventory is sold. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

~~Table of Contents~~

Risks and Uncertainties

Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others, labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In a number of states targeted flavor bans have been proposed or enacted legislatively or by the administrative process. Depending on the number and location of such bans, that legislation or regulation could have a material adverse effect on the Company’s financial position, results of operations or cash flows. The U.S. Food and Drug Administration (“FDA”) continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing, and ultimate implementation of such measures remain unclear.

Table of Contents

The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of Creative Distribution Solutions products due to malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

Master Settlement Agreement (MSA):

Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General) and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. Such companies are entitled to direct the investment of the escrowed funds and withdraw any appreciation but cannot withdraw the principal for twenty-five years from the year of each annual deposit, except to withdraw funds deposited pursuant to an individual state’s escrow statute to pay a final judgement to that state’s plaintiffs in the event of such a final judgement against the Company. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy to record amounts on deposit in the escrow account for prior years as a non-current asset. As of ~~June 30,~~March 31, 2024, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.4 million. At December 31, 2023, the Company had on deposit approximately $32.1 million, the fair value of which was approximately ~~$28.2 million. At December 31, 2022, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.0~~$28.7 million. The Company discontinued its generic category of MYO in 2019 and its Zig-Zagbranded MYO cigarette smoking tobacco in 2017. Thus, pending a change in MSA legislation, the Company has no remaining product lines covered by the MSA and will not be required to make future escrow deposits.

The Company has chosen to invest a portion of the MSA escrow, from time to time, in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity.

~~Table of Contents~~

Fair values for the U.S. Governmental agency obligations are Level 2 in the fair value hierarchy. The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

	As of June 30, 2023							As of December 31, 2022							As of March 31, 2024							As of December 31, 2023
			Gross			Estimated				Gross			Estimated				Gross			Estimated				Gross			Estimated
			Unrealized			Fair				Unrealized			Fair				Unrealized			Fair				Unrealized			Fair
	Cost		Losses			Value		Cost		Losses			Value		Cost		Gains (Losses)			Value		Cost		Losses			Value
Cash and cash equivalents	$	1,929	$	-		$	1,929	$	1,929	$	-		$	1,929	$	1,934	$	–		$	1,934	$	1,929	$	–		$	1,929
U.S. Governmental agency obligations (unrealized position < 12 months)		746		(59	)		687		10,226		(1,251	)		8,975		1,196		6			1,202		–		–			–
U.S. Governmental agency obligations (unrealized position > 12 months)		29,398		(3,785	)		25,613		19,918		(2,842	)		17,076		28,943		(3,652	)		25,291		30,144		(3,389	)		26,755
	$	32,073	$	(3,844	)	$	28,229	$	32,073	$	(4,093	)	$	27,980	$	32,073	$	(3,646	)	$	28,427	$	32,073	$	(3,389	)	$	28,684

	As of		As of
	June 30, 2023		March 31, 2024
Less than one year	$	2,199	$	3,250
One to five years		9,242		13,775
Five to ten years		16,748		11,159
Greater than ten years		1,955		1,955
Total	$	30,144	$	30,139

Table of Contents

The following shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of				Deposits as of
Sales Year	June 30, 2023		December 31, 2022		March 31, 2024		December 31, 2023
1999	$	211	$	211	$	211	$	211
2000		1,017		1,017		1,017		1,017
2001		1,673		1,673		1,673		1,673
2002		2,271		2,271		2,271		2,271
2003		4,249		4,249		4,249		4,249
2004		3,714		3,714		3,714		3,714
2005		4,553		4,553		4,553		4,553
2006		3,847		3,847		3,847		3,847
2007		4,167		4,167		4,167		4,167
2008		3,364		3,364		3,364		3,364
2009		1,619		1,619		1,619		1,619
2010		406		406		406		406
2011		193		193		193		193
2012		199		199		199		199
2013		173		173		173		173
2014		143		143		143		143
2015		101		101		101		101
2016		91		91		91		91
2017		82		82		82		82

Total	$	32,073	$	32,073	$	32,073	$	32,073

~~Table of Contents~~

~~FDA:~~On June 22, 2009, the Family Smoking Prevention and Tobacco Control Act (the “FSPTCA”) authorized the FDA to immediately regulate the manufacturing, sale, and marketing of four categories of tobacco products – cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. On August 8, 2016, the FDA deeming regulation became effective. The deeming regulation gave the FDA the authority to also regulate cigars, pipe tobacco, e-cigarettes, vaporizers, and e-liquids as “deemed” tobacco products under the FSPTCA.

The FDA currently assesses tobacco product user fees on six classes of regulated tobacco products and computes user fees using a methodology similar to the methodology used by the U.S Department of Agriculture to compute the Tobacco Transition Payment Program (“TTPP,” also known as the “Tobacco Buyout”) assessment. First, the total, annual, congressionally established user fee assessment is allocated among the various classes of tobacco products using the federal excise tax weighted market share of tobacco products subject to regulation. Then, the assessment for each class of tobacco products is divided among individual manufacturers and importers.

In August 2016, the FDA’s regulatory authority under the Tobacco Control Act (the “TCA”) was extended to all tobacco products not previously covered, including: (i) certain Creative Distribution Solutions products (such as electronic cigarettes, vaporizers and e-liquids) and their components or parts (such as tanks, coils and batteries); (ii) cigars and their components or parts (such as cigar tobacco and wraps); (iii) pipe tobacco; (iv) hookah products; and (v) any other tobacco product “newly deemed” by the FDA. These “deeming regulations” apply to all products made or derived from tobacco intended for human consumption, but excluding accessories of tobacco products (such as lighters). Accordingly, the FDA has since regulated our cigar and cigar wrap products as well as our vapor products containing tobacco-derived nicotine and products intended or reasonably expected to be used to consume such e-liquids.

Subsequently, on April 14, 2022, the FDA Center for Tobacco Products also obtained jurisdiction over non-tobacco nicotine products (“NTN Products”), including synthetic nicotine. That law subjects NTN Products to the same requirements as tobacco-derived products, including not selling these products to persons under 21 years of age, not marketing these products as modified risk tobacco products without authorization, and not distributing free samples of these products. Additionally, NTN Products became subject to premarket filing requirements. Under the new law, manufacturers were required to file a ~~Premarket Tobacco Application~~ (“PMTA”) by May 14, 2022, in order to continue selling products currently on the market. NTN Products subject of a timely-filed PMTA, and not in receipt of a negative action, were allowed to remain on the market until July 13, 2022, at which time these products became subject to enforcement, similar to tobacco-derived products remaining under review.

A successful PMTA must demonstrate that the subject product is “appropriate for the protection of public health,” taking into account the effect of the marketing of the product on all sub-populations while a Substantial Equivalence Report must demonstrate that a new product either has the same characteristics as its predicate product or different characteristics but does not raise different questions of public health. We submitted premarket filings for certain of our regulated products in order to continue selling these products while they remain under review. We have continued to supplement these applications with additional information and have responded to information requests from the FDA; however, there can be no guarantee that the FDA will accept such amendments and responses or that the applications will meet the standard of “appropriate for the protection of public health” or “substantially equivalent,” as appropriate. The FDA has indicated its enforcement priority is those applicants who have received negative action on their application, such as a Marketing Denial Order or Refuse to File notification and who continue to illegally sell those unauthorized products, as well as products for which manufacturers failed to submit a marketing application. Despite these stated enforcement priorities, given the FDA’s limited resources we expect that for a period of time there may be a lack of enforcement, which may adversely impact our ability to compete in the marketplace against those who continue to sell unauthorized products. There can be no guarantee that the FDA will not shift its enforcement priorities or that it will increase in ability to enforce against unauthorized products over time.

~~On October 5, 2021, the FDA finalized~~ ~~two~~ rules related to the Substantial Equivalence process and the Premarket Tobacco Product Application process, respectively, which both became effective November 4, 2021. Both final rules (collectively, the “Rules”) indicate that any new or additional requirements will not retroactively apply to currently pending PMTAs for tobacco and tobacco-derived products; however, the information outlined in the rule remains important to the FDA’s substantive review of an application. The FDA has yet to indicate how it might apply these Rules to NTN Product filings. We believe we have products that meet the Rules and have filed premarket filings supporting a showing of the respective required standards. However, there is no assurance that the FDA’s guidance or regulations will not change, or that the FDA will not prioritize its enforcement in a manner that negatively affects our pending applications, or that unforeseen circumstances will not arise that prevent us from sufficiently supplementing or completing our applications or otherwise increases the amount of time and money we are required to spend to receive all necessary marketing orders. Although we filed many premarket applications in a timely manner, no assurance can be given that the applications will ultimately be successful. This may result in the prioritization of supplementing or completing applications for high priority SKUs in our inventory position, which could adversely impact future revenues generated by lower priority SKUs.

~~Table of Contents~~

In addition, we currently distribute many third-party manufactured vapor products for which we are completely dependent on the manufacturer complying with the premarket filing requirements. There can be no assurance that these third-party products will receive a marketing order or otherwise remain in compliance with relevant legal requirements. While we will take measures to pursue regulatory compliance for our own privately-branded or proprietary vape products that compete with these third-party products, there is no assurance that such proprietary products would be as successful in the marketplace or can fully displace third-party products that are currently being distributed by us, which could adversely affect our results of operations and liquidity. ~~Additionally, FDA has limited resources, which may impact its ability to meaningfully enforce these provisions. This~~ may adversely affect our ability to compete in the marketplace against those who continue to sell unauthorized products; however, regulatory uncertainty in the FDA’s enforcement policies may likewise affect operations or sales of our proprietary products if the FDA’s policies or priorities shift.

~~On May 4, 2022, the FDA proposed~~ ~~two~~ tobacco product standards related to combusted tobacco products: (1) a ban on menthol as a characterizing flavor in cigarettes; and (2) a ban on all characterizing flavors (including menthol) in cigars. On June 21, 2022, the FDA also issued a proposed product standard related to restricting the level of nicotine in traditional cigarettes. These product standards are required to go through the formal rulemaking process where we have ~~had~~ ~~the opportunity to~~ ~~provide comments~~ ~~with regard to the impact such standards would have on our products.~~ ~~These proposed rules remain pending.~~ ~~The FDA’s policy on these and other regulated products may change or expand over time in ways not yet known and may significantly impact our products or our premarket filings.~~

~~Prevent All Cigarette Trafficking Act (“PACT Act”):~~ On December 27, 2020, President Trump signed the Further Consolidated Appropriations Act, 2021, into law. This law included an amendment to the Jenkins Act expanding the definition of “cigarette” to include “electronic nicotine delivery systems,” or ENDS, and required that the United States Postal Service (“USPS”) promulgate regulations clarifying the applicability of the prohibition on delivery sales of cigarettes to ENDS. USPS issued its final rule on October 21, 2021. We have received appropriate shipping exemptions from carrier services we use to carry the affected freight. Failure to comply with the PACT Act could result in significant financial or criminal penalties. To the extent we are unable to respond to, or comply with, these new requirements, we could lose our shipping exemptions, be subject to civil or criminal penalties, or there could be a material adverse effect on our business, results of operations and financial condition.

Note 3. Derivative Instruments

Foreign Currency

The Company’s policy is to manage the risks associated with foreign exchange rate movements. The policy allows hedging of up to 100% of its anticipated purchases of inventory over a forward period that will not exceed 12 rolling and consecutive months. The Company may, from time to time, hedge currency for non-inventory purchases, ~~e.g., production equipment, up to 100% of the purchase price.~~ During the ~~six~~three months ended March 31, 2024~~June 30, 2023~~, the Company executed ~~various~~no foreign exchange contracts ~~which met~~meeting hedge accounting ~~requirements for the purchase of~~requirements. ~~€10.9 million~~ ~~and the sale of~~ €~~6.0 million.~~

At ~~June 30, 2023~~,March 31, 2024, the Company had foreign currency contracts outstanding for the purchase of ~~€10.9~~€9.2 million and sale of ~~€6.0~~€9.2 million. The foreign currency contracts’ fair value at ~~June 30, 2023~~,March 31, 2024, resulted in an asset of ~~$0.2~~$0.0 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities. At December 31, ~~2022,~~2023, the Company had foreign currency contracts outstanding for the purchase of ~~€18.5~~€15.2 million and sale of ~~€18.5~~€15.2 million. The foreign currency contracts’ fair value at December 31, ~~2022,~~2023, resulted in an asset of ~~$1.2~~$0.3 million included in Other current assets and a liability of ~~$0.0~~$0.1 million included in Accrued liabilities.

Note 4. Fair Value of Financial Instruments

The estimated fair value amounts have been determined by the Company using the methods and assumptions described below. However, considerable judgment is required to interpret market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

Cash and Cash Equivalents

Cash and cash equivalents are, by definition, short-term. Thus, the carrying amount is a reasonable estimate of fair value.

~~Table of Contents~~

Accounts Receivable

The fair value of accounts receivable approximates their carrying value due to their short-term nature.

Table of Contents

Long-Term Debt

The Company’s Senior Secured Notes (as defined in Note 10) bear interest at a rate of 5.625% per year. As of ~~June 30, 2023~~March 31, 2024, the fair value approximated ~~$228.3~~$237.3 million, with a carrying value of $250 million. As of December 31, ~~2022,~~2023, the fair value of the Senior Secured Notes approximated ~~$226.4~~$234.9 million, with a carrying value of $250 million.

The Convertible Senior Notes (as defined in Note 10) bear interest at a rate of 2.50% per year, and the fair value of the Convertible Senior Notes without the conversion feature approximated $~~124.9~~117.5 million, with a carrying value of $~~133.5~~118.5 million as of ~~June 30, 2023~~March 31, 2024. As of December 31, ~~2022,~~2023, the fair value of the Convertible Senior Notes without the conversion feature approximated $~~139.2~~114.7 million, with a carrying value of $~~162.5~~118.5 million.

See Note 10, “Notes Payable and Long-Term Debt”, for further information regarding the Company’s long-term debt.

Note 5. Inventories

The components of inventories are as follows:

	June 30,		December 31,		March 31,		December 31,
	2023		2022		2024		2023
Raw materials and work in process	$	5,552	$	7,283	$	7,148	$	5,201
Leaf tobacco		55,794		43,468		41,461		34,894
Finished goods - Zig-Zag Products		42,855		42,279		39,103		41,783
Finished goods - Stoker’s Products		9,671		9,667		10,232		8,090
Finished goods - Creative Distribution Solutions		9,410		15,431		6,086		7,281
Other		1,774		1,787		1,437		1,711
Inventories	$	125,056	$	119,915	$	105,467	$	98,960

The inventory valuation allowance was ~~$4.2 million and $4.5~~$20.6 million as of ~~June 30, 2023~~March 31, 2024, and December 31, ~~2022, respectively.~~2023.

In December 2023, a third-party warehouse in Tennessee used to store some of the Company’s leaf tobacco incurred significant tornado damage resulting in damage to the leaf tobacco. As a result, the Company recorded a $15.2 million inventory reserve related to its leaf tobacco inventory which is included in Other operating income, net in the consolidated statement of income for the quarter ended December 31, 2023. The leaf tobacco inventory is covered by the Company’s stock throughput insurance policy and the Company believes the inventory loss is probable of being fully recovered under the policy. The Company does not expect to incur any delays in customer deliveries as a result of the damage.

Note 6. Other Current Assets

Other current assets consist of:

	June 30,		December 31,		March 31,		December 31,
	2023		2022		2024		2023
Inventory deposits	$	4,969	$	6,395	$	7,392	$	5,707
Insurance deposit		3,000		3,000		–		3,000
Prepaid taxes		976		448		–		153
Settlement receivable						–		4,000
Insurance recovery receivable						15,181		15,181
Other		9,271		13,116		11,864		12,740
Total	$	18,216	$	22,959	$	34,437	$	40,781

1814

Table of Contents

Note 7. Property, Plant, and Equipment

Property, plant, and equipment consists of:

	June 30,			December 31,			March 31,			December 31,
	2023			2022			2024			2023
Land	$	22		$	22		$	22		$	22
Buildings and improvements		3,096			3,096			4,217			3,956
Leasehold improvements		5,409			5,404			6,614			5,440
Machinery and equipment		28,451			25,832			28,568			29,751
Furniture and fixtures		9,403			9,264			8,439			8,391
Gross property, plant and equipment		46,381			43,618			47,860			47,560
Accumulated depreciation		(22,253	)		(20,830	)		(23,070	)		(22,260	)
Net property, plant and equipment	$	24,128		$	22,788		$	24,790		$	25,300

Note 8. Other Assets

Other assets consist of:

	June 30,		December 31,		March 31,		December 31,
	2023		2022		2024		2023
Equity investments	$	4,627	$	13,376
Non-marketable equity investments					$	2,882	$	2,405
Debt security investment		7,488		7,820		6,750		6,750
Capitalized software						6,108		5,923
Available-for-sale marketable securities						7,125		–
Other		6,093		1,453		88		88
Total	$	18,208	$	22,649	$	22,953	$	15,166

Debt and Non-Marketable Equity Investments

The Company records its non-marketable equity investments without a readily determinable fair value, that are not accounted for under the equity method, at cost, with adjustments for impairment and observable price changes. Should assumptions underlying the determination of the fair values of the Company’s non-marketable equity and debt security investments change, it could result in material future impairment charges.

In January 2024, the Company invested $0.8 million to acquire an 18.744% stake in Teaza Energy, LLC (“TeaZa”). TeaZa is an innovative brand of flavorful oral pouch products that can be dipped or sipped, designed as a health-conscious alternative to high energy drinks and other conventional oral stimulants. The investment is comprised of $0.5 million in cash and a $0.3 million payable to be offset against the Company’s allocated portion of future profit distributions. The Company also has options to purchase, at fair value, up to 51.744% of the equity interest in TeaZa between September 30, 2024 and January 31, 2025, and up to 100% of the equity interest from February 1, 2025 to June 30, 2026. The Company accounts for its investment in TeaZa using the equity method of accounting.

In July 2021, the Company invested $8.0 million in Old Pal Holding Company LLC (“Old Pal”). In July 2022, the Company invested an additional $1.0 million in Old Pal. The Company invested in the form of a convertible note which includes additional follow-on investment rights. The accrued interest of $0.2 million from July 2021 to July 2022 was rolled into the convertible note in July 2022 resulting in a total investment of $9.2 million. Old Pal is a leading brand in the cannabis lifestyle space that operates a non-plant touching licensing model. The convertible note bears an interest rate of 3.0% per year and matures July 31, 2026.Interest and principal not paid to date are receivable at maturity. Old Pal has the option to extend the maturity date in one-year increments. The interest rate is subject to change based on Old Pal reaching certain sales thresholds. The weighted average interest rate on the convertible note was 3.0% for the three ~~and six~~ months ended ~~June 30,~~March 31, 2024 and 2023. Old Pal has the option to convert the note into shares once sales reach a certain threshold. The conditions required to allow Old Pal to convert the note were not met as of ~~June 30, 2023.~~March 31, 2024. Additionally, the Company has the right to convert the note into shares at any ~~time after January 1, 2022.~~time. The Company has classified the debt security with Old Pal as available for sale. The Company reports interest income on available for sale debt securities in interest income in our Consolidated Statements of Income. Quarterly, we perform a qualitative assessment to determine if the fair value of the investment could be less than the amortized cost basis. The fourth quarter 2022 qualitative assessment determined that the fair value of the investment could be less than the amortized cost basis and therefore the Company performed a quantitative assessment of the fair value of the investment. The fair value as of December 31, 2022 was determined to be $7.9 million based on a Monte Carlo simulation (Level 3). The Company determined that the impairment was a result of credit related factors and, as such, recorded an allowance for credit losses of $1.4 million which is included in investment loss for the year ended December 31, 2022. In the second ~~quarter~~and fourth quarters of 2023, based on ~~a subsequent~~third-party quantitative ~~assessment~~assessments of the fair value using a Monte Carlo simulation (Level 3), the Company determined the fair value to be $7.7 million and 6.9 million, respectively, and recorded an ~~additional~~ allowance for credit losses of $0.3 million ~~which is~~and $1.0 million, respectively, included in investment loss for the ~~quarter~~quarters ended June 30 and December 31, 2023. The Company has recorded accrued interest receivable of ~~$0.3~~$0.2 million and $0.1 million at ~~June 30, 2023~~March 31, 2024 and December 31, ~~2022,~~2023, respectively, in ~~other~~Other current assets on our Consolidated Balance Sheets.

1915

Table of Contents

In April 2021, the Company invested $8.7 million in Docklight Brands, Inc., a pioneering consumer products company with celebrated brands including Marley ~~Natural® cannabis~~Natural® and ~~Marley™ CBD.~~Marley™. The Company has additional follow-on investment rights. As part of the investment, the Company has obtained exclusive U.S. distribution rights for Docklight’s ~~Marley~~™Marley™ CBD topical products. In the first quarter of 2023, based on Docklight’s financial results and other operating difficulties, and the decline in the revenue multiples for public companies comparable to Docklight, the Company deemed the investment in Docklight was impaired ~~resulting in the fair value of the Company’s investment decreasing to $3.8 million~~ resulting in a loss of $4.9 million which was recorded for the three months ended March 31, 2023. In the second quarter of 2023, based on a significant change in Docklight’s business model, the Company deemed its investment in Docklight fully impaired resulting in an additional loss of $3.8 million bringing the fair value of the Company’s investment in Docklight to zero. Impairment losses for the Company’s investment in Docklight are recorded in Investment loss on our Consolidated Statements of Income.impaired. Fair value for ~~both~~all periods presented was determined using a valuation derived from relevant revenue multiples (Level 3).

Available-for-Sale Marketable Securities

In December 2023, the Company formed a captive insurance company, Interchange IC, incorporated in the District of Columbia, to write a portion of our general product, and officer and director liability coverages under deductible reinsurance policies. Interchange IC is a fully licensed captive insurance company holding a certificate of authority from the District of Columbia Department of Insurance, Securities and Banking. Interchange IC is a wholly-owned subsidiary of Turning Point Brands and is consolidated in the Company’s financial statements.

The investments held within the captive are not available for operating activities and are carried at fair value on the consolidated balance sheet. They consist of money market, corporate bonds, government securities, real estate investment trusts and exchange traded funds. The Company believes any impairment of investments held with gross unrealized losses to be temporary and not the result of credit risk.

The Company’s captive investments are summarized in the following table.

	As of March 31, 2024
				Gross				Estimated
	Amortized			Unrealized				Fair
	Cost			Gains (Losses)				Value
Corporate bonds		$	1,703		$	8			$	1,711
U.S. Governmental agency obligations			1,799			(3	)			1,796
Real estate investment trusts and exchange traded funds			3,617			1				3,618
		$	7,119		$	6			$	7,125

The following table summarizes the fair value of the Company’s captive investments by contractual maturity.

	As of
	March 31, 2024
Due within one year	$	1,711
Due after ten years		1,796
Real estate investment trusts and exchange traded funds		3,618
Total investments at fair value	$	7,125

Note 9. Accrued Liabilities

Accrued liabilities consist of:

	June 30,		December 31,		March 31,		December 31,
	2023		2022		2024		2023
Accrued payroll and related items	$	4,729	$	7,685	$	4,669	$	7,085
Customer returns and allowances		7,444		7,291		4,642		5,239
Taxes payable		2,008		1,867		6,995		3,821
Lease liabilities		2,596		3,102		2,615		2,678
Accrued interest		6,830		7,277		2,221		6,682
Other		7,291		5,779		9,832		8,130
Total	$	30,898	$	33,001	$	30,974	$	33,635

Table of Contents

Note 10. Notes Payable and Long-Term Debt

Notes payable and long-term debt consists of the following in order of preference:

	June 30,			December 31,			March 31,			December 31,
	2023			2022			2024			2023
Senior Secured Notes	$	250,000		$	250,000		$	250,000		$	250,000
Convertible Senior Notes		133,541			162,500			118,541			118,541
Gross notes payable and long-term debt		383,541			412,500			368,541			368,541
Less deferred finance charges		(4,346	)		(5,743	)		(2,648	)		(3,183	)
Less current maturities								(59,397	)		(58,294	)
Notes payable and long-term debt	$	379,195		$	406,757		$	306,496		$	307,064

Senior Secured Notes

On February 11, 2021, the Company closed a private offering (the “Offering”) of ~~$250~~$250.0 million aggregate principal amount of its 5.625% senior secured notes due 2026 (the “Senior Secured Notes” or the “Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.The Company used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any ~~Credit Facility~~credit facility (as defined in the ~~Indenture~~indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

~~Table of Contents~~

The Company may redeem the Senior Secured Notes, in whole or in part, at any time ~~on or after February 15, 2023,~~ at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

If the Company experiences a change of control (as defined in the Senior Secured Notes Indenture), the Company must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. The Company was in compliance with all covenants as of ~~June 30, 2023.~~March 31, 2024.

The Company incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the ~~effective interest~~straight-line method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, the Company also entered into a ~~new~~ $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto ~~(the “Lenders”)~~ and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). On May 10, 2023, the Company and certain of its subsidiaries, as guarantors, entered into an amendment (the “Amendment”) to the 2021 Revolving Credit Facility (as amended, the “Amended Revolving Credit Facility”). The Amendment includes certain modifications to the 2021 Revolving Credit Facility relating to the replacement of the London Inter-Bank Offered Rate with a Secured Overnight Financing Rate (“SOFR”) as the interest rate benchmark under the 2021 Revolving Credit Facility and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

~~Letters~~Table of Contents

On November 7, 2023, in connection with the entry by a subsidiary of the Company in a new asset-backed revolving credit facility, the Company terminated the Amended Revolving Credit Facility. See “2023 ABL Facility” below.

The Company had letters of credit ~~are limited to $10.0~~ ~~million (and are a part of, and not in addition to, the revolving line of credit). The Company has~~ no~~t drawn any borrowings~~outstanding under the Amended Revolving Credit Facility ~~but does have letters of credit~~ of approximately $~~1.4~~$1.4 million ~~outstanding under~~that were terminated with the facility asin the fourth quarter of ~~June 30,~~ 2023. ~~The Amended Revolving Credit Facility will mature on~~ ~~August 11, 2025, if none of the Company’s Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is~~ 91 ~~days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.~~

Interest is payable on the Amended Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate or the Term SOFR rate, as applicable, plus an applicable margin of 3.50% (with step-downs upon de-leveraging). The Company also has the option to borrow at a rate determined by reference to the base rate.

The obligations under the Amended Revolving Credit Agreement are guaranteed on a joint and several basis by the Guarantors. The Company’s and Guarantors’ obligations under the Amended Revolving Credit Facility are secured on a pari passu basis with the Senior Secured Notes.

~~Table of Contents~~

The Amended Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The Amended Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio (as defined in the Amended Revolving Credit Agreement) of 5.50 to 1.00 (with a step down to 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the Amended Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $5.0 million) in the aggregate outstanding exceeds 35% of the total commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Agreement provides for customary events of default. ~~The Company was in compliance with all covenants as of June 30, 2023~~.

2023 ABL Facility

On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a new $75.0 million asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and Last In Last Out (“LILO”) Loans. The 2023 ABL Facility includes a $40.0 million accordion feature. In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.

~~0.5~~The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves. The 2023 ABL Facility also includes a LILO borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters if excess availability shall be less than the greater of (a) 12.5% of the line cap and (b) $9.4 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.4 million for thirty (30) consecutive calendar days; provided that such $9.4 million level shall automatically increase in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.

The 2023 ABL Facility shall mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

Table of Contents

The Company has not drawn any borrowings under the 2023 ABL Facility but has letters of credit of approximately $1.2 million outstanding under the facility and has an available balance of $59.0 million based on the borrowing base as of March 31, 2024.

The Company incurred debt issuance costs attributable to the 2023 ABL Facility of $2.6 million which are amortized to interest expense using the ~~effective interest~~straight-line method over the expected life of the ~~Amended Revolving Credit~~2023 ABL Facility.

~~Convertible Senior Notes~~

Convertible Senior Notes

Note 11. Leases

The Company’s leases consist primarily of leased property for manufacturing, warehouse, corporate offices and retail space, as well as vehicle leases. At lease inception, the Company recognizes a lease right of use asset and lease liability calculated as the present value of future minimum lease payments. In general, the Company does not recognize any renewal periods within the lease terms as there are no significant barriers to ending the lease at the initial term. Lease and non-lease components are accounted for as a single lease component.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for these leases is recognized on a straight-line basis over the lease term.

Table of Contents

The components of lease expense consisted of the following:

	Three Months Ended March 31,
	2024		2023
Operating lease cost
Cost of sales	$	133	$	128
Selling, general and administrative		464		521
Variable lease cost (1)		297		225
Short-term lease cost		–		6
Total	$	894	$	880

Three Months Ended
June 30,

2023
2022

Operating lease cost
Cost of sales $ 129 $ 233
Selling, general and administrative 503
386

Variable lease cost (1) 407
211

Short-term lease cost 7
11

Total $ 1,046 $ 841

(1)	Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

Three Months Ended June 30,
2023 2022
Financing lease cost
Selling, general and administrative $ 348 $ 297
Total $ 348 $ 297

Six Months Ended
June 30,

2023

2022

Operating lease cost
Cost of sales $ 257 $ 460
Selling, general and administrative 1,024
785

Variable lease cost (1) 632
323

Short-term lease cost 13
25

Total $ 1,926
$ 1,593

	Three Months Ended March 31,
	2024		2023
Financing lease cost
Selling, general and administrative	$	150	$	338
Total	$	150	$	338

Six Months Ended June 30,
2023 2022
Financing lease cost
Selling, general and administrative $ 686 $ 588
Total $ 686

$ 588

Right of use assets - Financing

Current lease liabilities - Financing (2)

Long-term lease liabilities - Financing

Note 12. Income Taxes

The Company’s effective income tax rate for the three ~~and six~~ months ended ~~June 30, 2023~~March 31, 2024 was ~~25.6% and 25.4%, respectively.~~23.4%. The Company’s effective income tax rate for the three ~~and six~~ months ended ~~June 30, 2022~~March 31, 2023 was ~~23.2% and 23.5%, respectively, which includes a discrete tax deduction of $0.3 million and $0.7 million, respectively, relating to stock option exercise~~s25.2%.

The Company follows the provisions of ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company has determined that the Company did not have any uncertain tax positions requiring recognition under the provisions of ASC 740-10-25. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of interest expense. The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. In general, the Company is no longer subject to U.S. federal and state tax examinations for years prior to ~~2019.~~2020.

Table of Contents

Note 13. Share Incentive Plans

On March 22, 2021, the Company’s Board of Directors adopted the Turning Point Brands, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2021 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2021 Plan, 1,290,000 shares, plus 100,052 shares remaining available for issuance under the 2015 Equity Incentive Plan (the “2015 Plan”), of TPB Common Stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2021 Plan is scheduled to terminate on March 21, 2031. The 2021 Plan is administered by the compensation committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in the award agreement. As of ~~June 30, 2023,~~March 31, 2024, net of forfeitures, there were ~~277,397~~400,682 Restricted Stock Units (“RSUs”), ~~120,746~~161,658 options and ~~30,559~~102,216 ~~Performance-Based~~Performance Based Restricted Stock Units (“PRSUs”) granted under the 2021 Plan. There are ~~961,350~~725,496 shares available for future grant under the 2021 Plan.

On April 28, 2016, the Board of Directors of the Company adopted the 2015 Plan, pursuant to which awards could have been granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provided for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2015 Plan, 1,400,000 shares of TPB Common Stock were reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2015 Plan was scheduled to terminate on April 27, 2026. Upon adoption of the 2021 Plan, the 2015 Plan was terminated, and the Company determined no additional grants would be made under the 2015 Plan. However, all awards issued under the 2015 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2015 Plan. ~~The 2015 Plan was administrated by the Committee.~~

On February 8, 2006, the Board of Directors of the Company adopted the 2006 Equity Incentive Plan (the “2006 Plan”) of North Atlantic Holding Company, Inc., pursuant to which ~~awards may be granted to employees. The 2006 Plan provides for the granting of~~ nonqualified stock options and restricted stock awards may be granted to employees. Upon the adoption of the Company’s 2015 Equity Incentive Plan in connection with its IPO, the Company determined no additional grants would be made under the 2006 Plan. However, all awards issued under the 2006 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2006 Plan.

~~Table of Contents~~

Stock option activity for the 2006, 2015 and 2021 Plans is summarized below:

				Weighted		Weighted					Weighted		Weighted
	Stock			Average		Average		Stock			Average		Average
	Option			Exercise		Grant Date		Option			Exercise		Grant Date
	Shares			Price		Fair Value		Shares			Price		Fair Value
Outstanding, December 31, 2021		619,835		$	28.51	$	8.70
Outstanding, December 31, 2022									683,214		$	29.74	$	9.24
Granted									77,519			20.71		6.45
Exercised									(33,851	)		13.30		4.24
Forfeited									(69,931	)		27.51		9.11
Outstanding, December 31, 2023									656,951		$	29.79	$	9.18

Granted		114,827			30.58		10.34		54,289			27.19		9.21
Exercised		(40,331	)		12.49		4.08		(198	)		14.85		4.41
Forfeited		(11,117	)		32.60		9.35		(6,433	)		30.19		8.85
Outstanding, December 31, 2022		683,214		$	29.74	$	9.24

Granted		77,519			20.71		6.45
Exercised		(29,371	)		13.84		4.37
Forfeited		(62,987	)		26.61		9.00
Outstanding, June 30, 2023		668,375		$	29.68	$	9.15
Outstanding, March 31, 2024									704,609		$	29.59	$	9.19

Under the 2006, 2015 and 2021 Plans, the total intrinsic value of options exercised during the ~~six~~three months ended ~~June 30,~~March 31, 2024 and 2023, ~~and 2022,~~ was ~~$0.2~~$0.0 million, and ~~$0.5~~$0.2 million, respectively.

At ~~June 30, 2023,~~March 31, 2024, under the 2006 Plan, the exercise price for the ~~46,824~~43,693 outstanding options is $3.83 per share, all of which are exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $3.83 is approximately ~~1.11~~0.35 years. The Company estimates the expected life of these stock options is ten years from the date of grant. For the $3.83 per share options, the weighted average fair value of options at the date of grant was determined using the Black-Scholes model with the following assumptions: a ten-year life from grant date, a current share price and exercise price of $3.83, a risk-free interest rate of 3.57%, volatility of 40%, and no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $2.17 per share option granted.

Table of Contents

At ~~June 30, 2023,~~March 31, 2024, under the 2015 and 2021 Plans, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.

The following table outlines the assumptions based on the number of options granted under the 2015 Plan.

	February 10,			May 17,			March 7,			March 20,			October 24,			March 18,			February 18,			May 3,			February 10,			May 17,			March 7,			March 20,			October 24,			March 18,			February 18,			May 3,
	2017			2017			2018			2019			2019			2020			2021			2021			2017			2017			2018			2019			2019			2020			2021			2021
Number of options granted		40,000			93,819			98,100			155,780			25,000			155,000			100,000			12,000			40,000			93,819			98,100			155,780			25,000			155,000			100,000			12,000
Options outstanding at June 30, 2023		20,000			39,983			51,567			125,984			25,000			82,068			91,287			12,000
Number exercisable at June 30, 2023		20,000			39,983			51,567			125,984			25,000			82,068			64,564			8,040
Options outstanding at March 31, 2024																										20,000			38,033			51,067			124,864			25,000			77,777			87,350			12,000
Number exercisable at March 31, 2024																										20,000			38,033			51,067			124,864			25,000			77,777			87,350			12,000
Exercise price	$	13.00		$	15.41		$	21.21		$	47.58		$	20.89		$	14.85		$	51.75		$	47.76		$	13.00		$	15.41		$	21.21		$	47.58		$	20.89		$	14.85		$	51.75		$	47.76
Remaining lives		3.62			3.88			4.69			5.73			6.32			6.72			7.64			7.85			2.87			3.13			3.94			4.97			5.57			5.97			6.89			7.09
Risk free interest rate		1.89	%		1.76	%		2.65	%		2.34	%		1.58	%		0.79	%		0.56	%		0.84	%		1.89	%		1.76	%		2.65	%		2.34	%		1.58	%		0.79	%		0.56	%		0.84	%
Expected volatility		27.44	%		26.92	%		28.76	%		30.95	%		31.93	%		35.72	%		28.69	%		29.03	%		27.44	%		26.92	%		28.76	%		30.95	%		31.93	%		35.72	%		28.69	%		29.03	%
Expected life		6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000
Dividend yield		-			-			0.83	%		0.42	%		0.95	%		1.49	%		0.55	%		0.59	%		–			–			0.83	%		0.42	%		0.95	%		1.49	%		0.55	%		0.59	%
Fair value at grant date	$	3.98		$	4.60		$	6.37		$	15.63		$	6.27		$	4.41		$	13.77		$	13.06		$	3.98		$	4.60		$	6.37		$	15.63		$	6.27		$	4.41		$	13.77		$	13.06

~~Table of Contents~~

The following table outlines the assumptions based on the number of options granted under the 2021 Plan.

	May 17,			March 14,			April 29,			May 12,			May 17,			March 14,			April 29,			May 12,			March 11,
	2021			2022			2022			2023			2021			2022			2022			2023			2024
Number of options granted		7,500			100,000			14,827			77,519			7,500			100,000			14,827			77,519			54,289
Options outstanding at June 30, 2023		7,500			73,816			14,827			77,519
Number exercisable at June 30, 2023		5,100			25,295			5,042			38,760
Options outstanding at March 31, 2024														7,500			70,690			14,827			77,519			54,289
Number exercisable at March 31, 2024														7,500			47,442			9,935			77,519			–
Exercise price	$	45.05		$	30.46		$	31.39		$	20.71		$	45.05		$	30.46		$	31.39		$	20.71		$	27.19
Remaining lives		7.88			8.71			8.84			9.87			7.13			7.96			8.08			9.12			9.95
Risk free interest rate		0.84	%		2.10	%		2.92	%		3.41	%		0.84	%		2.10	%		2.92	%		3.41	%		4.06	%
Expected volatility		31.50	%		35.33	%		35.33	%		34.51	%		31.50	%		35.33	%		35.33	%		34.51	%		35.09	%
Expected life		6.000			6.000			6.000			5.186			6.000			6.000			6.000			5.186			5.186
Dividend yield		0.63	%		1.01	%		0.98	%		1.61	%		0.63	%		1.01	%		0.98	%		1.61	%		1.26	%
Fair value at grant date	$	13.23		$	10.23		$	11.07		$	6.45		$	13.23		$	10.23		$	11.07		$	6.45		$	9.21

The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately ~~$0.5~~$0.3 million and ~~$0.3~~$0.0 million for the three months ended ~~June 30,~~March 31, 2024 and 2023, ~~and 2022, respectively. The Company recorded compensation expense related to the options of approximately $0.5 million and $0.5 million for the six months ended June 30, 2023 and 2022,~~ respectively. Total unrecognized compensation expense related to options at ~~June 30, 2023,~~March 31, 2024, is ~~$0.7~~$0.3 million, which will be expensed over ~~1.23~~0.75 years.

PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period provided the applicable service and performance conditions are satisfied. As of ~~June 30, 2023~~March 31, 2024, there are ~~460,334~~447,266 PRSUs outstanding. The following table outlines the PRSUs granted and outstanding as of March~~June 30, 2023~~ 31, 2024.

	March 20,		March 18,		December 28,		February 18,		March 14,		May 4,		March 18,		February 18,		March 14,		May 4,		March 1,
	2019		2020		2020		2021		2022		2023		2020		2021		2022		2023		2024
Number of PRSUs granted		92,500		94,000		88,169		100,000		49,996		133,577		94,000		100,000		49,996		133,578		111,321
PRSUs outstanding at June 30, 2023		77,380		85,410		31,040		88,490		44,437		133,577
PRSUs outstanding at March 31, 2024														80,910		82,190		40,325		132,520		111,321
Fair value as of grant date	$	47.58	$	14.85	$	46.42	$	51.75	$	30.46	$	22.25	$	14.85	$	51.75	$	30.46	$	22.25	$	26.52
Remaining lives		0.50		1.50		0.50		2.50		3.50		2.75		0.75		1.75		2.75		1.75		2.75

Table of Contents

The Company recorded compensation expense related to the PRSUs of approximately ~~$0.6~~$0.9 million and ~~$0.8~~$0.5 million in the consolidated statements of income for the three months ended ~~June 30,~~March 31, 2024 and 2023, and 2022, respectively, based on the probability of achieving the performance condition. The Company recorded compensation expense related to the PRSUs of approximately $1.1 million and $1.6 million in the consolidated statements of income for the six months ended June 30, 2023 and 2022, respectively, based on the probability of achieving the performance condition. Total unrecognized compensation expense related to these awards at ~~June 30, 2023,~~March 31, 2024, is ~~$7.3~~$6.1 million which will be expensed over the service periods based on the probability of achieving the performance condition.

~~Table of Contents~~

The Company has granted ~~229,553~~325,523 RSUs which are outstanding and vest over one to five years. The following table outlines the RSUs granted and outstanding as of ~~June 30, 2023~~March 31, 2024.

	March 14,		March 14,		April 29,		May 5,		May 5,		May 8,		March 14,		March 14,		April 29,		May 5,		May 8,		March 1,		March 11,
	2022		2022		2022		2023		2023		2023		2022		2022		2022		2023		2023		2024		2024
Number of RSUs granted		50,004		28,726		4,522		130,873		22,472		20,101		50,004		28,726		4,522		130,873		20,101		105,257		18,389
RSUs outstanding at June 30, 2023		43,860		18,961		4,522		130,873		11,236		20,101
RSUs outstanding at March 31, 2024														39,367		9,481		4,522		128,406		20,101		105,257		18,389
Fair value as of grant date	$	30.46	$	30.46	$	31.39	$	22.25	$	22.25	$	21.77	$	30.46	$	30.46	$	31.39	$	22.25	$	21.77	$	26.52	$	27.19
Remaining lives		3.50		1.50		3.50		2.75		0.50		0.86		2.75		0.75		2.75		2.00		0.10		3.00		0.75

The Company has recorded compensation expense related to the RSUs based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the RSUs on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the RSUs of approximately ~~$1.0~~$0.9 million and ~~$0.4~~$0.3 million for the three months ended ~~June 30, 2023~~March 31, 2024 and ~~2022. The Company recorded compensation expense related to the RSUs of approximately $1.3 million and $0.6 million for the six months ended June 30, 2023 and 2022, respectively.~~2023. Total unrecognized compensation expense related to RSUs at ~~June 30, 2023,~~March 31, 2024, is ~~$4.3~~$5.1 million, which will be expensed over ~~2.56~~2.52 years.

Note 14. Contingencies

On October 9, 2020, a purported stockholder of Turning Point Brands, Inc. ~~(“TPB” or the “Company”)~~, Paul-Emile Berteau, ~~(the “Plaintiff”),~~ filed a complaint in the Delaware Court of Chancery ~~(the “Court”)~~ relating to the merger of Standard Diversified, Inc. (“SDI”) with a TPB subsidiary (“Merger Sub”)pursuant to the Agreement and Plan of Merger and Reorganization, dated as of April 7, 2020, by and among TPB, SDI and Merger ~~Sub (“Action”).~~ Sub.The complaint purports to assert two derivative counts for breach of fiduciary duty on TPB’s behalf and against the TPB Board of Directors and certain SDI affiliates (collectively, the “Defendants”). The third count purports to assertparties attended a ~~direct claim against TPB and its Board of Directors based on allegations that TPB’s Amended and Restated Bylaws are inconsistent with TPB’s certificate of incorporation.~~mediation in late November 2022 where a settlement was reached. On ~~October 26, 2020, the TPB Board of Directors adopted Amendment No. 1 to TPB’s Amended and Restated Bylaws, which amended the challenged section of the bylaws. On June 30, 2021,~~December 12, 2023, the Court ~~granted in part and denied in part~~approved the ~~Defendants’ motions to dismiss. Among other things, the Court dismissed TPB director H.C. Charles Diao as a defendant in the action~~settlement and dismissed the ~~third count~~action with prejudice. As of ~~the Plaintiff’s complaint as moot.~~

~~The Defendants and~~December 31, 2023, the Company ~~deny any wrongdoing~~ ~~but~~ ~~following~~recorded a ~~mediation~~$4.0 million receivable in ~~November 2022,~~other current assets, and a corresponding gain on settlement in other income on its Consolidated Statement of Income for the ~~Defendants agreed to settle with the Plaintiff~~ to eliminate the distraction, burden, expense, risks and potential delay of further litigation involving the asserted claims. The parties entered into a Stipulation and Agreement of Compromise, Settlement and Release, dated and filed with the Court on June 27, 2023 (together with the exhibits thereto, the “Settlement Stipulation”). The material terms of the proposed settlement of the Action include, ~~among other things, that the Defendants’ insurers will pay or cause to be~~ ~~paid~~ year ended December 31, 2023. These funds were received in January 2024.~~an aggregate of $5,000,000~~ ~~into an escrow account (the “Settlement Payment”) in exchange for a release of~~ ~~all claims.~~ ~~Plaintiff also~~ intends to seek an award of attorneys’ fees and expenses to Plaintiff’s counsel of up to $1,000,000 and an additional mootness fee of up to $500,000 in connection with the third count of the complaint ~~that~~ ~~will be paid out of the Settlement Payment~~ ~~with~~ ~~the remaining funds paid to the Company. The proposed settlement is subject to~~, ~~and conditioned on approval by the Court, and no assurances can be given that such Court approval will be obtained. The impact to the Company is not expected to be material.~~

We have two franchisor subsidiaries. Like many franchise businesses, in the ordinary course of their business, these subsidiaries are from time-to-time responding parties to arbitration demands brought by franchisees. We have reached an agreement to arbitrate a claim brought by a former franchisee. This matter relates to the termination of the franchise agreement by the franchisor for failure to pay franchising fees and our subsequent demand that the franchisee cease using our marks and de-image locations formerly housing the franchises. The franchisee is claiming tortious interference and conversion. We believe the franchisor’s ultimate termination of the franchise agreement for multiple uncured material defaults by the franchisee was proper. We are party to another franchise arbitration with breach of contract and negligence allegations, among others. We believe we have good and valid substantive defenses against the claims and intend on vigorously defending our interests in these matters.

Note 15. Income Per Share

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:

	Three Months Ended March 31,
	2024						2023
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	12,010					$	7,597

Denominator
Weighted average				17,654,684	$	0.68				17,531,414	$	0.43

Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	12,010					$	7,597
Interest expense related to Convertible Senior Notes, net of tax		731						954
Diluted net income attributable to Turning Point Brands. Inc.	$	12,741					$	8,551

Denominator
Basic weighted average				17,654,684						17,531,414
Convertible Senior Notes				2,218,018						3,029,699
Stock options and restricted stock units				297,612						108,039
				20,170,314	$	0.63				20,669,152	$	0.41

Three Months Ended June 30,
2023 2022
Per Per
Income Shares Share Income Shares Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc. $ 9,925 $ 5,424

Denominator
Weighted average 17,584,241 $ 0.56 18,063,259 $ 0.30

Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc. $ 9,925 $ 5,424
Interest expense related to Convertible Senior Notes, net of tax 846 1,054
Diluted net income attributable to Turning Point Brands. Inc. $ 10,771 $ 6,478

Denominator
Basic weighted average 17,584,241 18,063,259
Convertible Senior Notes 2,625,714 3,211,484
Stock options and restricted stock units
199,988 168,536
20,409,943 $ 0.53 21,443,279 $ 0.30

~~Table of Contents~~

Six Months Ended June 30,
2023 2022
Per
Per
Income Shares Share Income Shares Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc. $ 17,522 $ 16,422

Denominator
Weighted average 17,556,030 $ 1.00 18,159,940 $ 0.90

Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc. $ 17,522 $ 16,422
Interest expense related to Convertible Senior Notes 1,800 2,108
Diluted net income attributable to Turning Point Brands. Inc. $ 19,322 $ 18,530

Denominator
Basic weighted average 17,556,030 18,159,940
Convertible Senior Notes 2,799,434 3,211,484
Stock options and restricted stock units
183,483 231,689
20,538,947 $ 0.94 21,603,113 $ 0.86

Note 16. Segment Information

In accordance with ASC 280, Segment Reporting, the Company has three reportable ~~segments:~~segments, (1) Zig-Zag Products; (2) Stoker’s Products; and (3) Creative Distribution Solutions. The Zig-Zag Products segment markets and distributes (a) rolling papers, tubes, and related products; ~~and~~ (b) finished cigars and MYO cigar wraps and (c) CLIPPER reusable ~~lighters.~~lighters and other accessories. The Stoker’s Products segment (a) manufactures and markets moist snuff and (b) contracts for and markets ~~loose leaf~~loose-leaf chewing tobacco products. The Creative Distribution Solutions segment (a) markets and distributes liquid ~~vapor~~nicotine products and certain other products without tobacco and/or nicotine; (b) distributes a wide assortment of products to non-traditional retail outlets via ~~VaporBeast;~~Vapor Beast; and (c) markets and distributes a wide assortment of products to individual consumers via the VaporFi B2C online platform. Products in the Zig-Zag Products and Stoker’s Products segments are distributed primarily through wholesale distributors in the U.S. and Canada while products in the Creative Distribution Solutions segment are distributed primarily through e-commerce to non-traditional retail outlets and direct to consumers in the U.S. Corporate unallocated includes the costs and assets of the Company not assigned to one of the three reportable segments such as intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries.

The accounting policies of these segments are the same as those of the Company. Corporate costs are not directly charged to the three reportable segments in the ordinary course of operations. The Company evaluates the performance of its segments and allocates resources to them based on operating income.

2824

Table of Contents

The tables below present financial information about reported segments:

	Three Months Ended March 31,
	2024			2023
Net sales
Zig-Zag products	$	46,697		$	41,887
Stoker’s products		36,367			33,662
Total Zig-Zag and Stoker’s products	$	83,064		$	75,549
Creative Distribution Solutions		13,994			25,407
Total	$	97,058		$	100,956

Gross profit
Zig-Zag products	$	27,538		$	22,390
Stoker’s products		20,815			19,465
Total Zig-Zag and Stoker’s products	$	48,353		$	41,855
Creative Distribution Solutions		3,559			6,762
Total	$	51,912		$	48,617

Operating income (loss)
Zig-Zag products	$	18,000		$	13,641
Stoker’s products		15,396			14,563
Corporate unallocated ⁽¹⁾⁽²⁾		(14,127	)		(10,623	)
Total Zig-Zag and Stoker’s products	$	19,269		$	17,581
Creative Distribution Solutions		(3	)		261
Total	$	19,266		$	17,842

Interest expense, net		3,479			4,010
Investment (income) loss		(119	)		4,799
Gain on extinguishment of debt		–			(777	)

Income before income taxes	$	15,906		$	9,810

Capital expenditures
Zig-Zag products	$	166		$	973
Stoker’s products		200			1,462
Total Zig-Zag and Stoker’s products	$	366		$	2,435
Creative Distribution Solutions		–			–
Total	$	366		$	2,435

Depreciation and amortization
Zig-Zag products	$	274		$	267
Stoker’s products		879			706
Total Zig-Zag and Stoker’s products	$	1,153		$	973
Creative Distribution Solutions		570			574
Total	$	1,723		$	1,547

Three Months Ended
June 30,

2023 2022

Net sales
Zig-Zag products $ 46,722 $ 46,226
Stoker’s products 36,056 33,588
Total Zig-Zag and Stoker’s products
$
82,778 $
79,814
Creative Distribution Solutions
22,817 23,111
Total $ 105,595 $ 102,925

Gross profit
Zig-Zag products $ 26,422 $ 26,430
Stoker’s products 19,968 18,079
Total Zig-Zag and Stoker’s products
$
46,390 $
44,509
Creative Distribution Solutions 6,088 6,960
Total $ 52,478 $ 51,469

Operating income (loss)
Zig-Zag products $ 17,000 $ 18,503
Stoker’s products 15,110 13,378
Corporate unallocated ⁽¹⁾⁽²⁾
(12,025 ) (14,287 )
Total Zig-Zag and Stoker’s products $
20,085 $
17,594
Creative Distribution Solutions
460 552
Total $ 20,545 $ 18,146

Interest expense, net 4,019 5,144
Investment loss
4,080 6,227
Gain on extinguishment of debt (600 ) -

Income before income taxes $ 13,046 $ 6,775

Capital expenditures
Zig-Zag products $ 112 $ 2,237
Stoker’s products 446 670
Total Zig-Zag and Stoker’s products
$
558 $
2,907
Creative Distribution Solutions - -
Total $ 558 $ 2,907

Depreciation and amortization
Zig-Zag products $ 267 $ 93
Stoker’s products 709 770
Total Zig-Zag and Stoker’s products
$
976 $
863
Creative Distribution Solutions 554 472
Total $ 1,530 $ 1,335

(1)	Includes corporate costs that are not allocated to any of the three reportable segments.

(2)	Includes costs related to PMTA of ~~$0.7~~$0.8 million in ~~2023~~2024 and ~~$2.0~~$0.1 million in ~~2022.~~ 2023.

2925

Table of Contents

	March 31,		December 31,
	2024		2023
Assets
Zig-Zag products	$	176,629	$	177,135
Stoker’s products		187,794		174,994
Corporate unallocated ⁽¹⁾		194,702		190,223
Total Zig-Zag and Stoker’s products	$	559,125	$	542,352
Creative Distribution Solutions		27,191		27,004
Total	$	586,316	$	569,356

Six Months Ended
June 30,

2023 2022

Net sales
Zig-Zag products $ 88,609 $ 91,898
Stoker’s products 69,718 65,291
Total Zig-Zag and Stoker’s products
$
158,327 $
157,189
Creative Distribution Solutions 48,224 46,630
Total $ 206,551 $ 203,819

Gross profit
Zig-Zag products $ 48,812 $ 52,773
Stoker’s products 39,433 35,765
Total Zig-Zag and Stoker’s products
$
88,245 $
88,538
Creative Distribution Solutions 12,850 14,725
Total $ 101,095 $ 103,263

Operating income (loss)
Zig-Zag products $ 30,641 $ 37,240
Stoker’s products 29,672 26,883
Corporate unallocated ⁽¹⁾⁽²⁾
(22,647 ) (27,978 )
Total Zig-Zag and Stoker’s products $
37,666 $
36,145
Creative Distribution Solutions 721 1,230
Total $ 38,387 $ 37,375

Interest expense, net 8,029 10,340
Investment loss
8,879 6,149
Gain on extinguishment of debt (1,377 ) -

Income before income taxes $ 22,856 $ 20,886

Capital expenditures
Zig-Zag products $ 1,085 $ 4,560
Stoker’s products 1,908 1,134
Total Zig-Zag and Stoker’s products $
2,993 $
5,694
Creative Distribution Solutions
- -
Total $ 2,993 $ 5,694

Depreciation and amortization
Zig-Zag products $ 534 $ 185
Stoker’s products 1,415 1,537
Total Zig-Zag and Stoker’s products
$
1,949 $
1,722
Creative Distribution Solutions
1,128 947
Total $ 3,077 $ 2,669

(1)	~~Includes corporate costs that are not allocated to any of the~~ ~~three~~ ~~reportable segments.~~

~~(2)~~

~~Includes costs related to PMTA of $0.8~~ ~~million in 2023 and $3.1 million in 2022.~~

~~Table of Contents~~

June 30, December 31,
2023 2022
Assets
Zig-Zag products $ 191,672 $ 225,893
Stoker’s products 168,326 151,241
Corporate unallocated ⁽¹⁾
167,190 155,348
Total Zig-Zag and Stoker’s products $
527,188 $
532,482
Creative Distribution Solutions
32,486 39,624
Total $ 559,674 $ 572,106

~~(1)~~

Includes assets not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments.

Revenue Disaggregation—Sales Channel

Revenues of the Zig-Zag Products and Stoker’s Products segments are primarily comprised of sales made to wholesalers while Creative Distribution Solutions sales are made business to business and business to consumer, both online and through our corporate retail stores. Creative Distribution Solutions net sales are broken out by sales channel below.

Note 17. Additional Information with Respect to Unrestricted Subsidiary

Under the terms of the Senior Secured Notes Indenture and Senior Secured Notes, the Company has designated its subsidiaries, South Beach Brands LLC, TPB Beast LLC and Intrepid Brands, LLC as “Unrestricted Subsidiaries”. South Beach Brands LLC is a holding company under which our vape business TPB Beast LLC operating as Creative Distribution Solutions sits. The Company is required under the terms of the Senior Secured Notes Indenture and the Senior Secured Notes to present additional information that reflects the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Company’s Unrestricted Subsidiaries as of and for the periods presented. This additional information is below.

Income Statement for the Three Months Ended ~~June 30,~~March 31, 2024 and 2023 ~~and 2022~~ (unaudited):

Three Months Ended June 30
2023
2022

Company and
Restricted
Subsidiaries

Unrestricted
Subsidiaries
Consolidated
Company and
Restricted
Subsidiaries

Unrestricted
Subsidiaries
Consolidated
Net sales $ 82,778 $ 22,817 $ 105,595 $ 79,814 $ 23,111 $ 102,925
Cost of sales 36,388 16,729 53,117 35,305 16,151 51,456
Gross profit 46,390 6,088 52,478 44,509 6,960 51,469
Selling, general, and administrative expenses 26,305 5,628 31,933 26,915 6,408 33,323
Operating income 20,085 460 20,545 17,594 552 18,146
Interest expense, net 4,019 - 4,019 5,144 - 5,144
Investment loss
4,080 - 4,080 6,227 - 6,227
Gain on extinguishment of debt (600 ) - (600 ) - - -
Income before income taxes 12,586 460 13,046 6,223 552 6,775
Income tax expense 3,220 118 3,338 1,441 128 1,569
Consolidated net income 9,366 342 9,708 4,782 424 5,206
Net loss attributable to non-controlling interest (217 ) - (217 ) (218 ) - (218 )
Net income attributable to Turning Point Brands, Inc. $ 9,583 $ 342 $ 9,925 $ 5,000 $ 424 $ 5,424

~~Income Statement for the Six Months Ended June 30, 2023 and 2022 (unaudited):~~

Six Months Ended June 30
2023 2022

Company and
Restricted
Subsidiaries
Unrestricted Subsidiaries Consolidated
Company and
Restricted
Subsidiaries
Unrestricted Subsidiaries Consolidated

Net sales $ 158,327 $ 48,224 $ 206,551 $ 157,189 $ 46,630 $ 203,819
Cost of sales 70,082 35,374 105,456 68,651 31,905 100,556
Gross profit 88,245 12,850 101,095 88,538 14,725 103,263
Selling, general, and administrative expenses 50,579 12,129 62,708 52,393 13,495 65,888
Operating income 37,666 721 38,387 36,145 1,230 37,375
Interest expense, net 8,029 - 8,029 10,340 - 10,340
Investment loss 8,879 - 8,879 6,149 - 6,149
Gain on extinguishment of debt (1,377 ) - (1,377 ) - - -
Income before income taxes 22,135 721 22,856 19,656 1,230 20,886
Income tax expense 5,623 183 5,806 4,620 289 4,909
Consolidated net income 16,512 538 17,050 15,036 941 15,977
Net loss attributable to non-controlling interest (472 ) - (472 ) (445 ) - (445 )
Net income attributable to Turning Point Brands, Inc. $ 16,984 $ 538 $ 17,522 $ 15,481 $ 941 $ 16,422

	Three Months Ended March 31
	2024									2023
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries			Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	83,064		$	13,994		$	97,058		$	75,549		$	25,407	$	100,956
Cost of sales		34,711			10,435			45,146			33,694			18,645		52,339
Gross profit		48,353			3,559			51,912			41,855			6,762		48,617
Selling, general, and administrative expenses		29,084			3,562			32,646			24,274			6,501		30,775
Operating income (loss)		19,269			(3	)		19,266			17,581			261		17,842
Interest expense, net		3,479			–			3,479			4,010			–		4,010
Investment (gain) loss		(119	)		–			(119	)		4,799			–		4,799
Gain on extinguishment of debt		–			–			–			(777	)		–		(777	)
Income (loss) before income taxes		15,909			(3	)		15,906			9,549			261		9,810
Income tax expense (benefit)		3,728			(1	)		3,727			2,402			66		2,468
Consolidated net income (loss)		12,181			(2	)		12,179			7,147			195		7,342
Net income (loss) attributable to non-controlling interest		169			–			169			(255	)		–		(255	)
Net income (loss) attributable to Turning Point Brands, Inc.	$	12,012		$	(2	)	$	12,010		$	7,402		$	195	$	7,597

3227

Table of Contents

Balance Sheet as of ~~June 30, 2023~~March 31, 2024 (unaudited):

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated		Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	96,701	$	3,806	$	-		$	100,507	$	126,066	$	4,837	$	–		$	130,903
Accounts receivable, net		7,550		370		-			7,920		8,198		–		–			8,198
Inventories		115,646		9,410		-			125,056
Inventories, net											99,381		6,086		–			105,467
Other current assets		15,103		3,113		-			18,216		32,836		1,601		–			34,437
Total current assets		235,000		16,699		-			251,699		266,481		12,524		–			279,005
Property, plant, and equipment, net		23,808		320		-			24,128		24,705		85		–			24,790
Deferred income taxes		7,966		-		-			7,966		1,426		–		–			1,426
Right of use assets		10,888		35		-			10,923		10,764		104		–			10,868
Deferred financing costs, net		229		-		-			229		2,305		–		–			2,305
Goodwill		136,244		-		-			136,244		136,365		–		–			136,365
Other intangible assets, net		66,646		15,402		-			82,048		66,199		13,978		–			80,177
Master Settlement Agreement (MSA) escrow deposits		28,229		-		-			28,229		28,427		–		–			28,427
Other assets		18,178		30		-			18,208		22,453		500		–			22,953
Investment in unrestricted subsidiaries		51,836		-		(51,836	)		-		62,732		–		(62,732	)		–
Total assets	$	579,024	$	32,486	$	(51,836	)	$	559,674	$	621,857	$	27,191	$	(62,732	)	$	586,316

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	9,449	$	1,353	$	-		$	10,802	$	18,596	$	338	$	–		$	18,934
Accrued liabilities		29,018		1,880		-			30,898		29,618		1,356		–			30,974
Other current liabilities		5		-		-			5
Current portion of long-term debt											59,397		–		–			59,397
Total current liabilities		38,472		3,233		-			41,705		107,611		1,694		–			109,305
Notes payable and long-term debt		379,195		-		-			379,195		306,496		–		–			306,496
Lease liabilities		9,528		-		-			9,528		9,327		33		–			9,360
Total liabilities		427,195		3,233		-			430,428		423,434		1,727		–			425,161

Commitments and contingencies

Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		150,653		29,253		(51,836	)		128,070
Total Turning Point Brands, Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries											197,232		25,464		(62,732	)		159,964
Non-controlling interest		1,176		-		-			1,176		1,191		–		–			1,191
Total stockholders’ equity		151,829		29,253		(51,836	)		129,246		198,423		25,464		(62,732	)		161,155
Total liabilities and stockholders’ equity	$	579,024	$	32,486	$	(51,836	)	$	559,674	$	621,857	$	27,191	$	(62,732	)	$	586,316

3328

Table of Contents

Balance Sheet as of December 31, ~~2022:~~2023:

ASSETS	Company and Restricted Subsidiaries		Unrestricted Subsidiaries			Eliminations			Consolidated		Company and Restricted Subsidiaries		Unrestricted Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	103,990	$	2,413		$	-		$	106,403	$	116,725	$	1,161	$	–		$	117,886
Accounts receivable, net		7,374		1,003			-			8,377		9,989		–		–			9,989
Inventories		104,883		15,032			-			119,915
Inventories, net												91,679		7,281		–			98,960
Other current assets		18,828		4,131			-			22,959		36,937		3,844		–			40,781
Total current assets		235,075		22,579			-			257,654		255,330		12,286		–			267,616
Property, plant, and equipment, net		22,261		527			-			22,788		25,142		158		–			25,300
Deferred income taxes		8,443		-			-			8,443		1,468		–		–			1,468
Right of use assets		12,328		137			-			12,465		11,359		121		–			11,480
Deferred financing costs, net		282		-			-			282		2,450		–		–			2,450
Goodwill		136,253		-			-			136,253		136,250		–		–			136,250
Other intangible assets, net		67,241		16,351			-			83,592		66,490		14,452		–			80,942
Master Settlement Agreement (MSA) escrow deposits		27,980		-			-			27,980		28,684		–		–			28,684
Other assets		22,619		30			-			22,649		15,166		–		–			15,166
Investment in unrestricted subsidiaries		60,120		-			(60,120	)		-		48,229		–		(48,229	)		–
Total assets	$	592,602	$	39,624		$	(60,120	)	$	572,106	$	590,568	$	27,017	$	(48,229	)	$	569,356

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:					��
Accounts payable	$	7,628	$	727		$	-		$	8,355	$	7,781	$	626	$	–		$	8,407
Accrued liabilities		31,118		1,883			-			33,001		32,052		1,583		–			33,635
Other current liabilities		20		-			-			20
Current portion of long-term debt												58,294		–		–			58,294
Total current liabilities		38,766		2,610			-			41,376		98,127		2,209		–			100,336
Notes payable and long-term debt		406,757		-			-			406,757		307,064		–		–			307,064
Lease liabilities		10,593		-			-			10,593		9,898		52		–			9,950
Total liabilities		456,116		2,610			-			458,726		415,089		2,261		–			417,350

Commitments and contingencies

Stockholders’ equity:
Total Turning Point Brands Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		134,751		37,014			(60,120	)		111,645
Total Turning Point Brands, Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries												174,449		24,756		(48,229	)		150,976
Non-controlling interest		1,735		-			-			1,735		1,030		–		–			1,030
Total stockholders’ equity		136,486		37,014			(60,120	)		113,380		175,479		24,756		(48,229	)		152,006
Total liabilities and stockholders’ equity	$	592,602	$	39,624		$	(60,120	)	$	572,106	$	590,568	$	27,017	$	(48,229	)	$	569,356

Note 18. Dividends and Share Repurchases

A dividend of ~~$0.065~~$0.07 per common share was paid on ~~July 7, 2023,~~April 12, 2024, to shareholders of record at the close of business on ~~June 16, 2023.~~March 22, 2024.

The Company currently pays a quarterly cash dividend. Dividends are considered restricted payments under the Senior Secured Notes ~~Indenture and 2021 Revolving Credit Facility.~~Indenture. The Company is generally permitted to make restricted payments provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional earnings and market capitalization restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year.

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022, in each case bringing the aggregate approval back to $50.0 million. ~~$27.2~~In the first quarter of 2024, the Company repurchased $2.1 million ~~remains~~of common stock, with $25.1 million remaining available for share repurchases under the program at ~~June 30, 2023.~~March 31, 2024.

3429

Table of Contents

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of the historical financial ~~condition~~conditions and results of operations in conjunction with our ~~historical~~ consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements which are subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”

The following Management’s Discussion and Analysis (“MD&A”) relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. The MD&A is intended to enable the reader to understand the Company’s financial condition and results of operations, including any material changes in the Company’s financial condition and results of operations since December 31, ~~2022,~~2023, and as compared with the three ~~and six~~ months ended ~~June 30, 2022.~~March 31, 2023. The MD&A is provided as a supplement to and should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in ~~the~~this Quarterly report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in the ~~2022~~ Annual ~~Report.~~Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Report”).

In this MD&A, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.

Overview

Turning Point Brands, Inc. ~~(the “Company,” “we,” “our,” or “us”)~~ is a leading manufacturer, marketer and distributor of branded consumer products. We sell a wide range of products to adult consumers consisting of staple products with our iconic brands Zig-Zag^®and Stoker’s^®and our next generation products to fulfill evolving consumer preferences. Among other markets, we compete in the alternative smoking accessories and Other Tobacco Products (“OTP”) industries. The alternative smoking accessories market is a dynamic market experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and positively evolving consumer perception and acceptance in North America. The OTP industry, which consists of non-cigarette tobacco products, exhibited ~~mid-single-digit~~low-single-digit consumer unit annualized growth over the ~~three-year~~four-year period ended ~~2022~~2023 as reported by Management Science Associates, Inc. ~~(“MSAi”),~~ a third-party analytics and information company. Our segments are led by our core proprietary and iconic brands: Zig-Zag^® and ~~CLIPPER~~^®CLIPPER® in the Zig-Zag Products ~~segment;~~ segment and Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment. Our businesses generate solid cash ~~flows~~flow which we use to invest in our business, finance acquisitions, increase brand support, expand our distribution infrastructure, and strengthen our capital position. We currently ship to approximately ~~800~~820 distributors with an additional ~~200~~650 secondary, indirect wholesalers in the U.S. that carry and sell our products. Under the leadership of a senior management team with extensive experience in the consumer products, alternative smoking accessories and tobacco industries, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.

We believe there are meaningful opportunities to grow through investing in organic growth, acquisitions and joint ventures across all product categories. Our products are currently available in approximately 197,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 217,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores, and we have a growing e-commerce business.

In the fourth quarter of 2022, we contributed our NewGen Products business to South Beach Holdings LLC doing business as Creative Distribution Solutions (“CDS”), a newly-formed wholly-owned subsidiary. CDS is separately operated and reports to its own Board of Directors. During the first quarter of 2023, the business was designated an unrestricted subsidiary under the Senior Secured Notes and concurrently we renamed what we previously referred to as our NewGen Products segment as our Creative Distribution Solutions segment as we believe this name better aligns with the goals and strategies of the segment.

~~Table of Contents~~

Products

We operate in three segments: Zig-Zag Products, Stoker’s Products and Creative Distribution Solutions. In our Zig-Zag Products segment, we principally market and distribute (i) rolling papers, tubes, and related products; ~~and~~ (ii) finished cigars and make-your-own (“MYO”) cigar ~~wraps~~wraps; and (iii) CLIPPER reusable lighters and other accessories. In addition, we have a majority stake in Turning Point Brands Canada which ~~markets~~is a specialty marketing and ~~distributes~~distribution firm focused on building brands in the Canadian cannabis accessories, tobacco and ~~tobacco~~alternative products ~~throughout Canada.~~categories. In our Stoker’s Products segment, we (i) manufacture and market moist snuff tobacco (“MST”) and (ii) contract for and market loose leaf chewing tobacco products. In our Creative Distribution Solutions segment, we (i) market and distribute liquid ~~vapor~~nicotine products and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of products to non-traditional retail via VaporBeast; and (iii) market and distribute a wide assortment of products to individual consumers via the VaporFi ~~and Direct Vapor~~ B2C online platform.

Table of Contents

Operations

Our core Zig-Zag Products and Stoker’s Products segments primarily generate revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of Vapor Beast in 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisition of IVG in 2018 enhanced our B2C revenue stream with the addition of the Vapor-Fi online platform. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. ~~More than~~Approximately 75% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists primarily of our moist snuff tobacco operations located in Dresden, Tennessee and Louisville, Kentucky. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. ~~Our other principal expenses include interest expense and other expenses.~~

Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

~~Our ability to further penetrate markets with our existing products;~~

~~Our ability to introduce new products and product lines that complement our core business;~~

●

Our ability to further penetrate markets with our existing products;

~~Decreasing interest in some tobacco products among consumers;~~

~~Price sensitivity in our end-markets;~~

~~Marketing and promotional initiatives, which cause variability in our results;~~

~~Cost and increasing regulation of promotional and advertising activities;~~

~~General economic conditions, including consumer access to disposable income and other conditions affecting purchasing power such as inflation;~~

~~Labor and production costs;~~

~~Cost of complying with regulation, including the “deeming regulation”;~~

~~Increasing and unpredictable regulation of Creative Distribution Solutions products;~~

~~Counterfeit and other illegal products in our end-markets;~~

~~Currency fluctuations;~~

~~Our ability to identify attractive acquisition opportunities; and~~

~~Our ability to successfully integrate acquisitions.~~

●

Our ability to introduce new products and product lines that complement our core business;

●

Decreasing interest in some tobacco products among consumers;

●

Price sensitivity in our end-markets;

●

Marketing and promotional initiatives, which cause variability in our results;

●

Costs and increasing regulation of promotional and advertising activities;

●

General economic conditions, including consumer access to disposable income and other conditions affecting purchasing power such as inflation and the interest rate environment;

●

Labor and production costs;

●

Cost of complying with regulation, including the “deeming regulation”;

●

Increasing and unpredictable regulation and/or marketing order decisions impacting Creative Distribution Solutions products;

●

Counterfeit and other illegal products in our end-markets;

●

Currency fluctuations;

●

Our ability to identify attractive acquisition opportunities; and

●

Our ability to successfully integrate acquisitions.

Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our ~~2022~~2023 Annual Report on Form 10-K.

Recent Accounting Pronouncements

There are no recent accounting pronouncements that impact the Company.

Recent Developments

Non-Marketable Equity Investments

In January 2024, the Company invested $0.8 million in Teaza Energy, LLC (“TeaZa”), an innovative brand of flavorful oral pouch products designed as a healthier alternative to high energy drinks and other oral stimulants. The Company’s investment is comprised of $0.5 million in cash and a $0.3 million payable to be offset against the Company’s allocated portion of future profit distributions.

Table of Contents

Results of Operations

Comparison of the Three Months Ended ~~June 30, 2023,~~March 31, 2024, to the Three Months Ended ~~June 30, 2022~~March 31, 2023

The table and discussion set forth below displays our consolidated results of operations (in thousands):

	Three Months Ended June 30,									Three Months Ended March 31,
	2023			2022			% Change			2024			2023			% Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products	$	46,722		$	46,226			1.1	%	$	46,697		$	41,887			11.5	%
Stoker’s products		36,056			33,588			7.3	%		36,367			33,662			8.0	%
Total Zig-Zag and Stoker’s products		82,778			79,814			3.7	%		83,064			75,549			9.9	%
Creative Distribution Solutions		22,817			23,111			-1.3	%		13,994			25,407			-44.9	%
Total net sales		105,595			102,925			2.6	%		97,058			100,956			-3.9	%
Cost of sales		53,117			51,456			3.2	%		45,146			52,339			-13.7	%
Gross profit
Zig-Zag products		26,422			26,430			0.0	%		27,538			22,390			23.0	%
Stoker’s products		19,968			18,079			10.4	%		20,815			19,465			6.9	%
Total Zig-Zag and Stoker’s products		46,390			44,509			4.2	%		48,353			41,855			15.5	%
Creative Distribution Solutions		6,088			6,960			-12.5	%		3,559			6,762			-47.4	%
Total gross profit		52,478			51,469			2.0	%		51,912			48,617			6.8	%

Selling, general, and administrative expenses		31,933			33,323			-4.2	%		32,646			30,775			6.1	%
Operating income		20,545			18,146			13.2	%		19,266			17,842			8.0	%
Interest expense, net		4,019			5,144			-21.9	%		3,479			4,010			-13.2	%
Investment loss		4,080			6,227			-34.5	%
Investment (gain) loss											(119	)		4,799			-102.5	%
Gain on extinguishment of debt		(600	)		-		NM				–			(777	)	NM
Income before income taxes		13,046			6,775			92.6	%		15,906			9,810			62.1	%
Income tax expense		3,338			1,569			112.7	%		3,727			2,468			51.0	%
Consolidated net income		9,708			5,206			86.5	%		12,179			7,342			65.9	%
Net loss attributable to non-controlling interest		(217	)		(218	)		-0.5	%
Net income (loss) attributable to non-controlling interest											169			(255	)		-166.3	%
Net income attributable to Turning Point Brands, Inc.	$	9,925		$	5,424			83.0	%	$	12,010		$	7,597			58.1	%

Net Sales: For the three months ended ~~June 30, 2023,~~March 31, 2024, consolidated net sales ~~increased~~decreased to ~~$105.6~~$97.1 million from ~~$102.9~~$101.0 million for the three months ended ~~June 30, 2022, an increase~~March 31, 2023, a decrease of ~~$2.7~~$3.9 million or ~~2.6%~~3.9%.

For the three months ended ~~June 30, 2023,~~March 31, 2024, net sales in the Zig-Zag Products segment increased to $46.7 million from ~~$46.2~~$41.9 million for the three months ended ~~June 30, 2022,~~March 31, 2023, an increase of ~~$0.5~~$4.8 million or ~~1.1%~~11.5%. The increase in net sales was driven by ~~strong~~ growth in our ~~Canadian~~U.S. papers and ~~other smoking accessories~~wraps businesses, partially offset by declines in ~~the U.S. rolling papers and wraps businesses.~~sales in our Clipper business against trade load in prior year.

For the three months ended ~~June 30, 2023,~~March 31, 2024, net sales in the Stoker’s Products segment increased to ~~$36.1~~$36.4 million from ~~$33.6~~$33.7 million for the three months ended ~~June 30, 2022,~~March 31, 2023, an increase of ~~$2.5~~$2.7 million or ~~7.3%~~8.0%. For the three months ended ~~June 30, 2023,~~March 31, 2024, volume increased ~~0.7%~~0.1% and price/product mix increased ~~6.6%~~7.9%. The increase in net sales was driven by ~~double-digit~~mid-single-digit growth of Stoker’s^® MST and triple-digit growth of our modern oral product FRE, partially offset by amid-single-digit decline in loose-leaf chewing tobacco.

For the three months ended ~~June 30, 2023,~~March 31, 2024, net sales in the Creative Distribution Solutions segment decreased to ~~$22.8~~$14.0 million from ~~$23.1~~$25.4 million for the three months ended ~~June 30, 2022,~~March 31, 2023, a decrease of ~~$0.3~~$11.4 million or ~~1.3%~~44.9%. The decrease in net sales was primarily the result of lower volumes in the ~~vape~~liquid nicotine distribution ~~businesses.~~business and our strategic decision to eliminate certain unprofitable brands and to focus on a narrower set of products.

Gross Profit: For the three months ended ~~June 30, 2023,~~March 31, 2024, consolidated gross profit increased to ~~$52.5~~$51.9 million from ~~$51.5~~$48.6 million for the three months ended ~~June 30, 2022,~~March 31, 2023, an increase of ~~$1.0~~$3.3 million or ~~2.0%~~6.8%. Gross profit as a percentage of net sales increased to 53.5% for the three months ended March 31, 2024, compared to 48.2% for the three months ended March 31, 2023 driven by product mix in our Zig-Zag Products segment.

Table of Contents

For the three months ended March 31, 2024, gross profit in the Zig-Zag Products segment increased to $27.5 million from $22.4 million for the three months ended March 31, 2023, an increase of $5.1 million or 23.0%. Gross profit as a percentage of net sales increased to 59.0% of net sales for the three months ended March 31, 2024, from 53.5% of net sales for the three months ended March 31, 2023, driven primarily by product mix.

For the three months ended March 31, 2024, gross profit in the Stoker’s Products segment increased to $20.8 million from $19.5 million for the three months ended March 31, 2023, an increase of $1.3 million or 6.9%. Gross profit as a percentage of net sales decreased to 49.7% for the three months ended June 30, 2023, compared to 50.0% for the three months ended June 30, 2022 driven by increased margin in the Stoker’s Products segment offset by decreased margin in the Zig-Zag Products and Creative Distribution Solutions segments as a result of price/product mix.

~~Table of Contents~~

For the three months ended June 30, 2023, gross profit in the Zig-Zag Products segment remained unchanged at $26.4 million compared to the three months ended June 30, 2022. Gross profit as a percentage of net sales decreased to 56.6% of net sales for the three months ended June 30, 2023, from 57.2% of net sales for the three months ended ~~June 30, 2022, driven primarily by~~ ~~product mix.~~

~~For the three months ended June 30, 2023, gross profit in the Stoker’s Products segment increased to $20.0 million~~March 31, 2024, from ~~$18.1 million for the three months ended June 30, 2022, an increase of $1.9 million or 10.4%. Gross profit as a percentage of net sales increased to 55.4%~~57.8% of net sales for the three months ended ~~June 30,~~March 31, 2023, ~~from 53.8% of net sales for the three months ended June 30, 2022,~~ primarily as a result of ~~strong market share~~product mix, as net sales of FRE were higher and ~~pricing gains~~have lower margins than other products in ~~MST.~~the segment.

For the three months ended ~~June 30, 2023,~~March 31, 2024, gross profit in the Creative Distribution Solutions segment decreased to ~~$6.1~~$3.6 million from ~~$7.0~~$6.8 million for the three months ended ~~June 30, 2022,~~March 31, 2023, a decrease of ~~$0.9~~$3.2 million or ~~12.5%~~47.4%. Gross profit as a percentage of net sales decreased to ~~26.7%~~25.4% of net sales for the three months ended ~~June 30, 2023,~~March 31, 2024, from ~~30.1%~~26.6% of net sales for the three months ended ~~June 30, 2022,~~March 31, 2023, primarily as a result of ~~product mix.~~channel mix and our strategic decision to eliminate certain unprofitable brands and to focus on a narrower set of products.

Selling, General, and Administrative Expenses: For the three months ended ~~June 30, 2023,~~March 31, 2024, selling, general, and administrative expenses ~~decreased~~increased to ~~$31.9~~$32.6 million from ~~$33.3~~$30.8 million for the three months ended ~~June 30, 2022, a decrease~~March 31, 2023, an increase of ~~$1.4~~$1.9 million or ~~4.2%~~6.1%. Selling, general and administrative expenses in the three months ended ~~June 30, 2023,~~March 31, 2024, included $2.1 million of stock options, restricted stock and incentives expense, ~~$0.7~~$0.8 million of expense related to PMTA, ~~$0.1~~$1.3 million of ~~transaction costs~~expense related to corporate restructuring, and $0.1 million of expense related to the new ERP and CRM systems. Selling, general and administrative expenses in the three months ended ~~June 30, 2022,~~March 31, 2023, included ~~$1.5~~$0.7 million of stock ~~option,~~options, restricted stock and incentives expense, ~~$0.4 million of transaction costs, $2.0~~$0.2 million of expense related to PMTA ~~$0.3 million of expense related to corporate restructuring~~ and ~~$0.9~~$0.1 million of consulting expense related to the scoping and mobilization of the new ERP and CRM systems.

Interest Expense, net: For the three months ended ~~June 30, 2023,~~March 31, 2024, interest expense, net decreased to ~~$4.0~~$3.5 million from ~~$5.1~~$4.0 million for the three months ended ~~June 30, 2022~~March 31, 2023 as a result of ~~the repurchase of $39.0 million of Convertible Senior Notes in the fourth quarter of 2022 and the first half of 2023, and~~ increased interest income on cash deposits as a result of rising interest rates.

Investment (Gain) Loss: For the three months ended ~~June 30, 2023,~~March 31, 2024, we had an investment ~~loss decreased to $4.1~~gain of $0.1 million compared to a ~~$6.2~~$4.8 million loss for the three months ended ~~June 30, 2022.~~March 31, 2023. The change is a result of ~~the~~an impairment charge recognized on our investment in Docklight for ~~$3.7~~$4.9 million in the ~~second quarter 2023 compared to an impairment charge of $6.3 million in the second~~first quarter of ~~2022 related to our investment in Dosist.~~2023.

Gain on Extinguishment of Debt: There was ano gain ~~on extinguishment of debt of $0.6 million for the three months ended June 30, 2023 as a result of repurchasing $15.1 million of Convertible Senior Notes compared to no gain~~or loss on extinguishment of debt for the three months ended ~~June 30, 2022.~~March 31, 2024 compared to a $0.8 million gain for the three months ended March 31, 2023 as a result of repurchasing $13.9 million of Convertible Senior Notes in the first quarter of 2023.

Income Tax Expense: Our income tax expense of ~~$3.3~~$3.7 million was ~~25.6%~~23.4% of income before income taxes for the three months ended ~~June 30, 2023.~~March 31, 2024. Our effective income tax rate was ~~23.2%~~25.2% for the three months ended ~~June 30, 2022~~ ~~and included a discrete tax benefit $0.3 million relating to stock option exercises.~~March 31, 2023.

Net ~~Loss~~Income (Loss) Attributable to Non-Controlling Interest: Net ~~loss~~gain attributable to non-controlling interest was $0.2 million for the three months ended ~~June 30, 2023~~March 31, 2024 compared to ~~$0.2~~$0.3 million net loss for the three months ended ~~June 30, 2022.~~March 31, 2023.

Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the three months ended ~~June 30,~~March 31, 2024 and 2023, ~~and 2022,~~ was ~~$9.9~~$12.0 million and ~~$5.4~~$7.6 million, respectively.

~~Table of Contents~~

~~Comparison of the Six Months Ended June 30, 2023, to the Six Months Ended June 30, 2022~~

~~The table and discussion set forth below displays our consolidated results of operations (in thousands):~~

Six Months Ended June 30,
2023 2022 % Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products $ 88,609 $ 91,898 -3.6 %
Stoker’s products 69,718 65,291 6.8 %
Total Zig-Zag and Stoker’s products 158,327 157,189 0.7 %
Creative Distribution Solutions 48,224 46,630 3.4 %
Total net sales 206,551 203,819 1.3 %
Cost of sales 105,456 100,556 4.9 %
Gross profit
Zig-Zag products 48,812 52,773 -7.5 %
Stoker’s products 39,433 35,765 10.3 %
Total Zig-Zag and Stoker’s products 88,245 88,538 -0.3 %
Creative Distribution Solutions 12,850 14,725 -12.7 %
Total gross profit 101,095 103,263 -2.1 %

Selling, general, and administrative expenses 62,708 65,888 -4.8 %
Operating income 38,387 37,375 2.7 %
Interest expense, net 8,029 10,340 -22.4 %
Investment loss 8,879 6,149 44.4 %
Gain on extinguishment of debt (1,377 ) - NM
Income before income taxes 22,856 20,886 9.4 %
Income tax expense 5,806 4,909 18.3 %
Consolidated net income 17,050 15,977 6.7 %
Net loss attributable to non-controlling interest (472 ) (445 ) 6.1 %
Net income attributable to Turning Point Brands, Inc. $ 17,522 $ 16,422 6.7 %

~~Net Sales:~~ ~~For the six months ended June 30, 2023, consolidated net sales increased to $206.6 million from $203.8 million for the six months ended June 30, 2022, an increase of $2.7 million or 1.3%.~~

For the six months ended June 30, 2023, net sales in the Zig-Zag Products segment decreased to $88.6 million from $91.9 million for the six months ended June 30, 2022, a decrease of $3.3 million or 3.6%. The decrease in net sales was driven by anticipated declines in the U.S. rolling papers and wraps businesses which were impacted by reduction of trade inventory during the period, offset by growth in our Canadian and other smoking accessories businesses.

For the six months ended June 30, 2023, net sales in the Stoker’s Products segment increased to $69.7 million from $65.3 million for the six months ended June 30, 2022, an increase of $4.4 million or 6.8%. For the six months ended June 30, 2023, volume increased 0.4% and price/product mix increased 6.4%. The increase in net sales was driven by double-digit growth of ~~Stoker’s~~^® ~~MST.~~

For the six months ended June 30, 2023, net sales in the Creative Distribution Solutions segment increased to $48.2 million from $46.6 million for the six months ended June 30, 2022, an increase of $1.6 million or 3.4%. The increase in net sales was primarily the result of improved volumes in the vape distribution businesses.

~~Gross Profit:~~ For the six months ended June 30, 2023, consolidated gross profit decreased to $101.1 million from $103.3 million for the six months ended June 30, 2022, a decrease of $2.2 million or 2.1%. Gross profit as a percentage of net sales decreased to 48.9% for the six months ended June 30, 2023, compared to 50.7% for the six months ended June 30, 2022 driven by increased margin in the Stoker’s Products segment offset by decreased margin in the Zig-Zag Products and Creative Distribution Solutions segments as a result of product mix.

~~Table of Contents~~

For the six months ended June 30, 2023, gross profit in the Zig-Zag Products segment decreased to $48.8 million from $52.8 million for the six months ended June 30, 2022, a decrease of $4.0 million or 7.5%. Gross profit as a percentage of net sales decreased to 55.1% of net sales for the six months ended June 30, 2023, from 57.4% of net sales for the six months ended June 30, 2022, as a result of product mix including the decline in net sales of higher margin U.S. rolling paper and wraps products and contribution of CLIPPER lighters, as a result of the exclusive distribution deal entered into in February, 2022, which operates at lower gross profit margins.

For the six months ended June 30, 2023, gross profit in the Stoker’s Products segment increased to $39.4 million from $35.8 million for the six months ended June 30, 2022, an increase of $3.7 million or 10.3%. Gross profit as a percentage of net sales increased to 56.6% of net sales for the six months ended June 30, 2023, from 54.8% of net sales for the six months ended June 30, 2022, primarily as a result of the strong incremental margin contribution of MST.

For the six months ended June 30, 2023, gross profit in the Creative Distribution Solutions segment decreased to $12.9 million from $14.7 million for the six months ended June 30, 2022, a decrease of $1.9 million or 12.7%. Gross profit as a percentage of net sales decreased to 26.6% of net sales for the six months ended June 30, 2023, from 31.6% of net sales for the six months ended June 30, 2022, primarily as a result of product mix.

~~Selling, General, and Administrative Expenses:~~ For the six months ended June 30, 2023, selling, general, and administrative expenses decreased to $62.7 million from $65.9 million for the six months ended June 30, 2022, a decrease of $3.2 million or 4.8%. Selling, general and administrative expenses in the six months ended June 30, 2023, included $2.8 million of stock options, restricted stock and incentives expense, $0.8 million of expense related to PMTA, $0.3 million of expense related to the new ERP and CRM systems and $0.1 million related to transaction costs. Selling, general and administrative expenses in the six months ended June 30, 2022, included $2.7 million of stock option, restricted stock and incentives expense, $0.8 million of transaction costs, $3.1 million of expense related to PMTA, $1.6 million of expense related to corporate restructuring and $1.2 million of consulting expense related to the scoping of the new ERP and CRM systems.

~~Interest Expense, net:~~ For the six months ended June 30, 2023, interest expense, net decreased to $8.0 million, from $10.3 million for the six months ended June 30, 2022 as a result of the repurchases of $39.0 million of Convertible Senior Notes in the fourth quarter of 2022 and the first and second quarters of 2023, and increased interest income on cash as a result of rising interest rates.

~~Investment Loss:~~ For the six months ended June 30, 2023, investment loss increased to $8.9 million compared to $6.1 million for the six months ended June 30, 2022. The change is a result of the impairment charge recognized on our investment in Docklight for $6.5 million in the first half of 2023 compared to an impairment charge of $6.3 million in the second quarter of 2022 related to our investment in Dosist.

~~Gain on Extinguishment of Debt:~~ There was a gain on extinguishment of debt of $1.4 million for the six months ended June 30, 2023 as a result of repurchasing $29.0 million of Convertible Senior Notes during the first and second quarters of 2023 compared to no gain on extinguishment of debt for the six months ended June 30, 2022.

~~Income Tax Expense:~~ ~~Our income tax expense of $5.8 million was 25.4% of income before income taxes for the six months ended June 30, 2023. Our effective income tax rate was 23.5% for the six months ended June 30, 2022~~ ~~and included a discrete tax benefit $0.7 million relating to stock option exercises.~~

~~Net Loss Attributable to Non-Controlling Interest:~~ ~~Net loss attributable to non-controlling interest was $0.5 million for the six months ended June 30, 2023 compared to $0.4 million for the six months ended June 30, 2022.~~

~~Net Income Attributable to Turning Point Brands, Inc.:~~ ~~Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the six months ended June 30, 2023 and 2022, was $17.5 million and $16.4 million, respectively.~~

~~Table of Contents~~

EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our debt instruments contain covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider the ordinary course in our evaluation of ongoing operating performance noted in the reconciliation below.

Table of Contents

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

(in thousands)	Three Months Ended June 30,					Three Months Ended March 31,
	2023			2022		2024		2023
Net income attributable to Turning Point Brands, Inc.	$	9,925		$	5,424	$	12,010	$	7,597
Add:
Interest expense, net		4,019			5,144		3,479		4,010
Gain on extinguishment of debt		(600	)		-		–		(777	)
Income tax expense		3,338			1,569		3,727		2,468
Depreciation expense		759			879		837		776
Amortization expense		771			456		886		771
EBITDA	$	18,212		$	13,472	$	20,939	$	14,845
Components of Adjusted EBITDA
Corporate restructuring (a)		-			270
Corporate and CDS restructuring (a)							1,261		–
ERP/CRM (b)		138			861		138		138
Stock options, restricted stock, and incentives expense (c)		2,093			1,502		2,062		743
Transactional expenses (d)		82			364
Transactional expenses and strategic initiatives (d)							30		4
FDA PMTA (e)		662			1,957		841		158
Non-cash asset impairment (f)		4,092			6,300		–		4,897
Adjusted EBITDA	$	25,279		$	24,726	$	25,271	$	20,785

(a)	Represents costs associated with corporate and CDS restructuring, including severance.

(b)	Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.

(c)	Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.

(d)	Represents the fees incurred for transaction expenses.

(e)	Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”).

(f)	Represents impairment of investment assets.

~~Table of Contents~~

(in thousands)
Six Months Ended
June 30,

2023 2022
Net income attributable to Turning Point Brands, Inc. $ 17,522 $ 16,422
Add:
Interest expense, net 8,029 10,340
Gain on extinguishment of debt (1,377 ) -
Income tax expense 5,806 4,909
Depreciation expense 1,535 1,750
Amortization expense 1,542 919
EBITDA $ 33,057 $ 34,340
Components of Adjusted EBITDA
Corporate restructuring (a) - 1,602
ERP/CRM (b) 276 1,191
Stock options, restricted stock, and incentives expense (c) 2,836 2,661
Transactional expenses (d) 86 789
FDA PMTA (e) 820 3,096
Non-cash asset impairment (f) 8,989 6,300
Adjusted EBITDA $ 46,064 $ 49,979

~~(a)~~

~~Represents costs associated with corporate restructuring, including severance.~~

~~(b)~~

~~Represents cost assosicated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.~~

~~(c)~~

~~Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.~~

~~(d)~~

~~Represents the fees incurred for transaction expenses.~~

~~(e)~~

~~Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”).~~

~~(f)~~

~~Represents impairment of investment assets.~~

Liquidity and Capital Resources

As of March 31, 2024, we have $130.9 million of cash on hand and have $59.0 million of availability under the 2023 ABL Facility. Our principal uses for cash are working capital, debt service, and capital expenditures. ~~We believe~~

Our Convertible Senior Notes, with an outstanding balance of $118.5 million as of March 31, 2024, mature in July 2024. On November 7, 2023, one of our wholly-owned subsidiaries entered into the 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior Notes at maturity. As a result, we classified $59.0 million (our current availability under the 2023 ABL Facility based on borrowing base calculations) related to the Convertible Senior Notes in long-term liabilities on our March 31, 2024 Consolidated Balance Sheet. With our strong cash ~~on hand,~~balance, free cash ~~flows from operations~~flow generation and borrowing availability under ~~our 2021 Revolving Credit~~the 2023 ABL Facility, ~~are adequate~~we expect to have ample liquidity to address the remaining balance of the Convertible Senior Notes maturing in July, and to satisfy our operating cash requirements for the foreseeable future. As of June 30, 2023, we had $100.5 million of cash on hand and have $23.6 million of availability under the 2021 Revolving Credit Facility. Subsequent to the balance sheet date the Convertible Senior Notes became current in the amount of $133.5 million. Based on the current liquidity, free cash flow generation and other financing options, we believe there will be adequate liquidity to address the maturity of the Convertible Senior Notes.

Our working capital, which we define as current assets less cash and current liabilities, decreased ~~$0.4 million~~ to ~~$109.5~~$38.8 million at ~~June 30, 2023,~~March 31, 2024, compared with ~~$109.9~~$49.4 million at December 31, ~~2022.~~2023. The decrease in working capital is primarily a result of the timing of inventory payments as well as $3.0 million insurance deposits being invested in investments.

	As of				As of
(in thousands)	June 30, 2023		December 31, 2022		March 31, 2024		December 31, 2023

Current assets	$	151,192	$	151,251	$	148,102	$	149,730
Current liabilities		41,705		41,376		109,305		100,336
Working capital	$	109,487	$	109,875	$	38,797	$	49,394

Table of Contents

Cash Flows from Operating Activities

For the ~~six~~three months ended ~~June 30, 2023,~~March 31, 2024, net cash provided by operating activities was ~~$27.5~~$22.6 million compared to net cash provided by operating activities of ~~$7.1~~$15.4 million for the ~~six~~ three months ended ~~June 30, 2022,~~March 31, 2023, an increase of ~~$20.4~~$7.2 million, primarily due to the timing of changes ~~of inventory and~~in other working ~~capital.~~capital and net income from operations.

~~Table of Contents~~

Cash Flows from Investing Activities

For the ~~six~~ three months ended ~~June 30, 2023,~~March 31, 2024, net cash used in investing activities was ~~$3.0~~$8.0 million compared to net cash used in investing activities of ~~$15.7~~$2.4 million for the ~~six~~ three months ended ~~June 30, 2022, a reduction~~March 31, 2023, an increase in cash used in investing activities of ~~$12.7~~$5.6 million, primarily due to ~~a decrease~~an increase in purchases of ~~investments of $10.7 million in our MSA escrow account.~~captive insurance investments.

Cash Flows from Financing Activities

For the ~~six~~three months ended ~~June 30, 2023,~~March 31, 2024, net cash used in financing activities was ~~$30.4~~$4.6 million compared to net cash used in financing activities of ~~$22.5~~$14.6 million for the ~~six~~three months ended ~~June 30, 2022, an increase~~March 31, 2023, a decrease of ~~$7.9~~$10.0 million, primarily due to ~~$27.4~~an increase in repurchases of common stock of $2.1 million during the period, offset by $13.0 million in repurchases of Convertible Senior Notes during the same period ~~offset by a decrease~~ in ~~repurchases of common stock of $19.4 million during~~ 2023.

Dividends and Share Repurchase

A dividend of ~~$0.065~~$0.07 per common share was paid on ~~July 7, 2023,~~April 12, 2024, to shareholders of record at the close of business on ~~June 16, 2023.~~March 22, 2024.

On February 25, 2020, our Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the ~~Board.~~Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022. ~~$27.2~~In the first quarter of 2024, the Company repurchased $2.1 million ~~remains~~of common stock, with $25.1 million remaining available for share repurchases under the program ~~at June 30, 2023.~~as of March 31, 2024.

Long-Term Debt

~~As of June 30, 2023, we were in compliance with the financial~~

Notes payable and ~~restrictive covenants~~long-term debt consisted of the ~~Senior Secured Notes~~following at March 31, 2024 and ~~2021 Revolving Credit Facility. The following table provides outstanding balances~~December 31, 2023, in order of ~~our debt instruments.~~preference:

	June 30, 2023			December 31, 2022			March 31, 2024			December 31, 2023
Senior Secured Notes	$	250,000		$	250,000		$	250,000		$	250,000
Convertible Senior Notes		133,541			162,500			118,541			118,541
Gross notes payable and long-term debt		383,541			412,500			368,541			368,541
Less deferred finance charges		(4,346	)		(5,743	)		(2,648	)		(3,183	)
Less current maturities								(59,397	)		(58,294	)
Notes payable and long-term debt	$	379,195		$	406,757		$	306,496		$	307,064

Senior Secured Notes

On February 11, 2021, we closed a private offering (the “Offering”) of $250 million aggregate principal amount of our 5.625% senior secured notes due 2026 (the “Senior Secured Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.We used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

4335

Table of Contents

The Company may redeem the Senior Secured Notes, in whole or in part, at any time, ~~on or after February 15, 2023,~~ at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	~~102.813%~~	102.813	%
On or after February 15, 2024	~~101.406%~~	101.406	%
On or after February 15, 2025 and thereafter	~~100.000%~~	100.000	%

If we experience a change of control (as defined in the Senior Secured Notes Indenture), we must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. We were in compliance with all covenants as of ~~June 30, 2023.~~March 31, 2024.

We incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the ~~effective interest~~straight-line method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, we also entered into a ~~new~~ $25.0 million senior secured revolving credit facility (the “~~2021~~“2021 Revolving Credit Facility”) with the lenders party thereto ~~(the “Lenders”)~~ and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). ~~On May 10,~~This facility was terminated in November 2023 in connection with the entry by a subsidiary of the Company ~~and certain of its subsidiaries, as guarantors, entered into an amendment (the “Amendment”) to the 2021 Revolving Credit Facility (as amended, the “Amended Revolving Credit~~in a new asset-backed revolving credit facility. See “2023 ABL Facility”). The Amendment includes certain modifications to the 2021 Revolving Credit Facility relating to the replacement of the London Inter-Bank Offered Rate with a Secured Overnight Financing Rate as the interest rate benchmark under the 2021 Revolving Credit Facility and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

Letters of credit are limited to $10.0 million (and are a part of, and not in addition to, the revolving line of credit). We have not drawn any borrowings under the Amended Revolving Credit Facility but do have letters of credit of approximately $1.4 million outstanding under the facility as of March 31, 2023. The Amended Revolving Credit Facility will mature on August 11, 2025 if none of our Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is 91 days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.

Interest is payable on the Amended 2021 Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate of Term SOFR rate, as applicable, plus an applicable margin of 3.50% (with step-downs upon de-leveraging). We also have the option to borrow at a rate determined by reference to the base rate.

The Amended Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The Amended Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio (as defined in the Amended Revolving Credit Agreement) of 5.50 to 1.00 (with a step down to 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the Amended Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $5.0 million) in the aggregate outstanding exceeds 35% of the total commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Agreement provides for customary events of default. We were in compliance with all covenants as of June 30, 2023.

~~Table of Contents~~

below. We incurred debt issuance costs attributable to the issuance of the ~~Amended~~2021 Revolving Credit Facility of $0.5 million, with the remaining $0.2 million written off to gain on debt extinguishment upon termination of the facility.

2023 ABL Facility

The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves. The 2023 ABL Facility also includes a LILO borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Table of Contents

Level	Historical Excess Availability	Applicable Margin for SOFR Loans	Applicable Margin for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility will mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

Convertible Senior Notes

In July 2019, wethe Company closed an offering of $172.5 million in aggregate principal amount of ~~our~~its 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes ~~will mature on July 15, 2024, unless earlier repurchased, redeemed or converted. The Convertible Senior Notes~~ are senior unsecured ~~obligations.~~obligations of the Company.

In ~~the fourth quarter of 2022,~~2023, a wholly owned subsidiary of the Company repurchased ~~$10.0~~$44.0 million in aggregate principal amount of the Convertible Senior Notes on the open market resulting in a ~~$0.9~~$1.9 million gain on extinguishment of debt. Subsequent repurchases occurred in the first and second quarters of 2023 for $13.9 million and $15.1 million, respectively, in aggregate principal amounts resulting in gains on extinguishment of debt of $0.7 million and $0.6 million, respectively. The repurchased notes continue to be held by our subsidiary and may be resold subject to compliance with applicable securities law. As of ~~June 30, 2023, $133.5~~March 31, 2024, $118.5 million aggregate principal remains outstanding and held by third parties.

The Convertible Senior Notes held by third parties are convertible into approximately ~~2,455,360~~2,219,704 shares of ~~our voting common stock~~TPB Common Stock under certain circumstances prior to maturity at a conversion rate of ~~18.6789~~18.7252 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately ~~$53.54~~$53.40 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by usthe Company in excess of pre-determined thresholds of $0.04 per share. Upon conversion, wethe Company may pay cash, shares of ~~our~~ common stock or a combination of cash and stock, as determined by usthe Company at ~~our~~its discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of ~~June 30, 2023.~~March 31, 2024.

Table of Contents

As discussed above, on November 7, 2023, a wholly-owned subsidiary of the Company entered into the 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior notes at maturity. As a result, the Company classified $59.0 million related to the Convertible Senior Notes in Notes payable and long-term debt on the Company’s March 31, 2024 Consolidated Balance Sheets. Based on current liquidity, free cash flow generation and availability under the 2023 ABL Facility, the Company believes it will have sufficient liquidity to address the maturity of the remaining Convertible Senior Notes.

The Company incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to ~~the~~ interest expense using the ~~effective interest~~straight-line method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, wethe Company entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of ~~$53.54~~$53.40 per share and a cap price of $82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. WeThe Company paid $20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

Off-balance Sheet Arrangements

During the ~~six~~three months ended ~~June 30,~~March 31, 2024, the Company executed no foreign exchange contracts meeting hedge accounting requirements. At March 31, 2024, we had foreign currency contracts outstanding for the purchase of €9.2 million and sale of €9.2 million, with maturities ranging from April to September 2024. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of $0.0 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities at March 31, 2024. During 2023, we executed various foreign exchange contracts for the purchase of ~~€10.9~~€20.1 million and sale of ~~€6.0 million with maturity dates ranging from August 2023 to October 2023.~~€15.2 million. At ~~June 30,~~December 31, 2023, we had foreign currency contracts outstanding for the purchase of ~~€10.9~~€15.2 million and sale of ~~€6.0~~€15.2 million. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of ~~$0.2~~$0.3 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities at ~~June 30, 2023. During 2022, we executed various foreign currency contracts for the purchase of €28.9 million and sale of €28.9 million. At~~ December 31, 2022, we had foreign currency contracts for the purchase of €18.5 million and sale of €18.5 million. The fair value of the foreign currency contracts resulted in an asset of $1.2 million included in Other current assets and a liability of $0.0 million included in Accrued liabilities at December 31, 2022.2023.

Inflation

Inflation in general, ~~and the recent rapid~~coupled with increases in gas prices have had a substantial negative effect on the purchasing power of consumers. While historically, we have been able to increase prices at a rate equal to or greater than that of inflation, doing so would be difficult in the current inflationary environment. However, we have implemented price increases in areas where doing so has been feasible. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement regarding our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

~~Table of Contents~~

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Sensitivity

~~There~~During the quarter ended March 31, 2024, there have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our ~~2022~~2023 Annual Report on Form ~~10-K, during the period.~~10-K. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our ~~2022~~2023 Annual Report on Form 10-K filed with the SEC.

Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our ~~2022~~2023 Annual Report on Form 10-K, during the ~~six~~three months ended ~~June~~ ~~30, 2023~~.March 31, 2024. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our ~~2022~~2023 Annual Report on Form 10-K filed with the SEC.

Interest Rate Sensitivity

In February 2021, we issued the Senior Secured Notes in an aggregate principal amount of $250 million. In July 2019, we issued Convertible Senior Notes in an aggregate principal amount of $172.5 million. We carry the Senior Secured Notes and Convertible Senior Notes at face value. Since the Senior Secured Notes and Convertible Senior Notes bear interest at a fixed rate, we have no financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Senior Notes changes when the market price of our stock fluctuates, or interest rates change. Our remaining debt instrument is a revolving credit facility, which has no borrowing outstanding.

Table of Contents

Item 4. Controls and Procedures

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of ~~1934, as amended (the “Act”))~~1934), as of ~~June~~ ~~30, 2023~~.March 31, 2024. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are not effective as of such date solely due to material weaknesses in internal controls over financial reporting that were disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2022.~~2023.

As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2022,~~

2023, during our evaluation of the effectiveness of our internal control over financial reporting as of December 31, ~~2022,~~2023, we concluded that our internal control over financial reporting was not effective solely due to the existence of the following material ~~weaknesses: we~~weakness:

We did not design and maintain effective internal controls related to our information technology general controls (“ITGCs”) in the areas of user access and program change-management over certain information technology (“IT”) systems that support the Company’s financial reporting processes. Our business process controls (automated and manual) that are dependent on the affected ITGCs were also deemed ineffective because they could have been adversely impacted. We ~~also did not appropriately design~~believe that these control deficiencies were a result of: IT control processes lacking sufficient documentation such that the successful operation of ITGCs was overly dependent upon knowledge and ~~operate controls associated~~actions of certain individuals with ~~the risk assessment component of the internal control framework, specifically as it relates to identifying risks around segregation of duties within the financial reporting function,~~IT expertise and the identification of all risks relating to the financial statements and controls that would address such risks. This impacts business process controls (automated and manual) throughout financial reporting and the business transaction cycles.inherent system limitations.

The material ~~weaknesses~~weakness did not result in any identified misstatements to ~~the~~our financial statements, and there were no changes to previously released financial results. The material ~~weaknesses~~weakness will not be considered remediated until the applicable controls operate for a sufficient period of time, and management has concluded through testing that these controls are operating effectively.

~~During the fiscal quarter ended June 30, 2023, we continued to make progress on~~Remediation Plan

While our remediation ~~plans~~plan may evolve and expand, management has been implementing and continues to ~~address~~implement measures designed to ensure that control deficiencies contributing to the material ~~weaknesses in the Company’s internal control over financial reporting. These~~weakness are remediated, such that these controls are designed, implemented, and operating effectively. The remediation ~~efforts include hiring additional experienced accounting and internal control specialists and external consultants. In addition, the Company is in process~~actions include: (i) implementation of ~~redesigning key controls for both business processes and information technology controls along with implementing~~ a new ~~enterprise resource planning system.~~ERP system in 2024; (ii) developing and maintaining documentation underlying ITGCs; (iii) implementing an IT management review and testing plan to monitor ITGCs with a specific focus on systems supporting our financial reporting processes; and (iv) enhanced quarterly reporting on the remediation measures to the Audit Committee of the Board of Directors.

We believe that these actions will remediate the material weakness. The material weakness will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

4639

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

For a description of our material pending legal proceedings, please see Contingencies in Note 14 to the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report.

On October 9, 2020, a purported stockholder of the Company, Paul-Emile Berteau (the “Plaintiff”), filed a complaint in the Delaware Court of Chancery (the “Court”) relating to the merger of Standard Diversified, Inc. (“SDI”) with a TPB subsidiary pursuant to the Agreement and Plan of Merger and Reorganization, dated as of April 7, 2020, by and among TPB, SDI and Merger Sub (the “Action”). The complaint purports to assert two derivative counts for breach of fiduciary duty on TPB’s behalf and against the TPB Board of Directors and certain SDI affiliates (collectively, the “Defendants”). The complaint also purports to assert a direct claim against TPB and its Board of Directors based on allegations that TPB’s Amended and Restated Bylaws are inconsistent with TPB’s certificate of incorporation. On October 26, 2020, the TPB Board of Directors adopted Amendment No. 1 to TPB’s Amended and Restated Bylaws, which amended the challenged section of the bylaws. On June 30, 2021, the Court granted in part and denied in part the Defendants’ motions to dismiss. Among other things, the Court dismissed TPB director H.C. Charles Diao as a defendant in the action and dismissed the third count of the Plaintiff’s complaint as moot.

The Defendants and the Company deny that any of them has committed or threatened to commit any violations of law, breaches of duty or other wrongdoing arising out of or related to any of the conduct, statements, acts or omissions alleged by Plaintiff, and maintain that their conduct was at all times proper, in the best interests of the Company and its stockholders, and in compliance with applicable law. Nevertheless, following a mediation in November 2022, the Defendants agreed to settle with the Plaintiff, because doing so will eliminate the distraction, burden, expense, risks and potential delay of further litigation involving the asserted claims. The parties entered into a Stipulation and Agreement of Compromise, Settlement and Release, dated and filed with the Court on June 27, 2023 (together with the exhibits thereto, the “Settlement Stipulation”). The Settlement Stipulation includes as an exhibit thereto a Notice of Pendency of Settlement of Action (the “Notice”). On July 12, 2023, the Court approved the form of the Notice. The material terms of the proposed settlement of the Action are summarized in the Notice and include, without limitation, that the Defendants’ insurers ~~will~~ ~~pay or cause to be paid~~ ~~an aggregate of~~ $5,0~~00,000 into an escrow account (the “Settlement Payment”) in exchange for a release of~~ ~~all claims.~~ The Court has scheduled a hearing on the proposed settlement for November 9, 2023, at 3:15 p.m. at the Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware 19801 to consider whether the terms of the settlement are fair, reasonable, and adequate and whether to approve Plaintiff’s counsel’s request for attorneys’ fees. Also, as described in the Notice, Plaintiff intends to seek an award of attorneys’ fees and expenses related to Plaintiff’s counsel of up to $1,000,000 and an additional mootness fee of up to $500,000 in connection with the third count of the complaint. Any fee awarded to Plaintiff’s counsel will be paid out of the Settlement Payment and the remaining funds will be paid to the Company. The proposed settlement is subject to, and conditioned on approval by the Court, and no assurances can be given that such Court approval will be obtained. The impact to the Company is not expected to be material.

A copy of the Notice is attached hereto as Exhibit 99.1, and a copy of the Settlement Stipulation, including the Notice, will be available on the Company’s website at https://www.turningpointbrands.com/investor-relations/resources/notice-of-proposed-settlement/default.aspx. The foregoing description of the terms and provisions of the proposed settlement as set forth in the Notice is a summary only, does not purport to be complete, and is qualified in its entirety by reference to the full text of the Settlement Stipulation, which text is incorporated herein by reference. Interested parties are encouraged to read the entire text of the Settlement Stipulation and the Notice carefully for further information. Information on our website is not incorporated by reference into this Quarterly Report on Form 10-Q.

See ‘Risk Factors—We ~~may become~~are subject to significant product liability litigation’ within our ~~2022~~2023 Annual Report on Form 10-K for additional details.

Item ~~1A.~~1A. Risk Factors

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our ~~2022~~2023 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the ~~2022~~2023 Annual Report on Form 10-K.

~~Table of Contents~~

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million bringing the authority at the time back to $50.0 million (including approximately $19.3 million available for repurchases under the ~~Board’s~~Board of Directors’ previous authorization). On February 24, 2022, the Board of Directors increased the approved share repurchase program by $24.6 million bringing total authority at that time to $50.0 million. This share repurchase program has no expiration date and is subject to the ongoing discretion of the Board of Directors. All repurchases to date under our stock repurchase programs have been made through open market transactions, but in the future, we may also purchase shares through privately negotiated transactions or 10b5-1 repurchase plans.

The following table includes information regarding purchases of our common stock made by us during the quarter ended ~~June 30, 2023~~March 31, 2024 in connection with the repurchase program described above.

⁽¹⁾ The total number of shares purchased includes shares withheld by the Company in an amount equal to the statutory withholding taxes for holders who vested in stock-based awards (which totaled 4,431 shares in April). Shares withheld by the Company to cover statutory withholdings taxes are repurchased pursuant to the applicable plan and not the authorization under the share repurchase program.

Item 4. Mine Safety Disclosures

Item 5. Other Information

~~None~~Not applicable.

~~Amendment No 1. Dated as of May 10, 2023, to~~Employment Agreement by and between the ~~Credit Agreement,~~Company and Andrew Flynn, dated as of ~~February 11, 2021, by and among Turning Point Brands, Inc., the obligors party thereto, Barclays Bank PLC, as administrative agent, and the lenders party thereto~~March 6, 2024 (incorporated herein by reference to Exhibit 10.1 of Turning Point ~~Brand,~~Brands, Inc’s Current Report on Form 8-K filed with the Commission on ~~May 16, 2023~~March 12, 2024 (File No. 001-37763)).

Rule 13a-14(a)/15d-14(a) Certification of Graham Purdy.*

Rule 13a-14(a)/15d-14(a) Certification of ~~Luis Reformina.~~Andrew Flynn.*

Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*

Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

*	Filed or furnished herewith

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Title: President and Chief Executive Officer

Title: Chief Financial Officer

Title: Chief Accounting Officer

	March 31,		December 31,
	2024		2023
Assets:
Right of use assets - Operating	$	8,714	$	8,950
Right of use assets - Financing		2,154		2,530
Total lease assets	$	10,868	$	11,480

Liabilities:
Current lease liabilities - Operating (2)	$	1,946	$	1,991
Current lease liabilities - Financing (2)		669		687
Long-term lease liabilities - Operating		7,925		8,374
Long-term lease liabilities - Financing		1,435		1,576
Total lease liabilities	$	11,975	$	12,628

	June 30,		December 31,
	2023		2022
Assets:
Right of use assets - Operating	$	9,983	$	10,967
Right of use assets - Financing		940		1,498
Total lease assets	$	10,923	$	12,465

Liabilities:
Current lease liabilities - Operating (2)	$	1,947	$	2,007
Current lease liabilities - Financing (2)		649		1,095
Long-term lease liabilities - Operating		9,272		10,243
Long-term lease liabilities - Financing		256		350
Total lease liabilities	$	12,124	$	13,695

	Six Months Ended June 30,
	2023			2022

Net sales	$	206,551		$	203,819
Cost of sales		105,456			100,556
Gross profit		101,095			103,263
Selling, general, and administrative expenses		62,708			65,888
Operating income		38,387			37,375
Interest expense, net		8,029			10,340
Investment loss		8,879			6,149
Gain on extinguishment of debt		(1,377	)		-
Income before income taxes		22,856			20,886
Income tax expense		5,806			4,909
Consolidated net income		17,050			15,977
Net loss attributable to non-controlling interest		(472	)		(445	)
Net income attributable to Turning Point Brands, Inc.	$	17,522		$	16,422

Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	1.00		$	0.90
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.94		$	0.86
Weighted average common shares outstanding:
Basic		17,556,030			18,159,940
Diluted		20,538,947			21,603,113

	Six Months Ended June 30,
	2023		2022
Financing lease cost
Selling, general and administrative	$	686	$	588
Total	$	686	$	588

					Creative Distribution Solutions Segment
	Creative Distribution Solutions Segment				Three Months Ended
	Three Months Ended				March 31,
	June 30,				2024		2023
	2023		2022
Business to Business	$	20,038	$	17,674	$	12,585	$	22,493
Business to Consumer - Online		2,525		5,336		1,380		2,810
Other		254		101		29		104
Total	$	22,817	$	23,111	$	13,994	$	25,407

	Creative Distribution Solutions Segment
	Six Months Ended
	June 30,
	2023		2022
Business to Business	$	42,531	$	36,798
Business to Consumer - Online		5,335		9,569
Other		358		263
Total	$	48,224	$	46,630

	Three Months Ended June 30
	2023								2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated
Net sales	$	82,778		$	22,817	$	105,595		$	79,814		$	23,111	$	102,925
Cost of sales		36,388			16,729		53,117			35,305			16,151		51,456
Gross profit		46,390			6,088		52,478			44,509			6,960		51,469
Selling, general, and administrative expenses		26,305			5,628		31,933			26,915			6,408		33,323
Operating income		20,085			460		20,545			17,594			552		18,146
Interest expense, net		4,019			-		4,019			5,144			-		5,144
Investment loss		4,080			-		4,080			6,227			-		6,227
Gain on extinguishment of debt		(600	)		-		(600	)		-			-		-
Income before income taxes		12,586			460		13,046			6,223			552		6,775
Income tax expense		3,220			118		3,338			1,441			128		1,569
Consolidated net income		9,366			342		9,708			4,782			424		5,206
Net loss attributable to non-controlling interest		(217	)		-		(217	)		(218	)		-		(218	)
Net income attributable to Turning Point Brands, Inc.	$	9,583		$	342	$	9,925		$	5,000		$	424	$	5,424

	Six Months Ended June 30
	2023								2022
	Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated			Company and Restricted Subsidiaries			Unrestricted Subsidiaries		Consolidated

Net sales	$	158,327		$	48,224	$	206,551		$	157,189		$	46,630	$	203,819
Cost of sales		70,082			35,374		105,456			68,651			31,905		100,556
Gross profit		88,245			12,850		101,095			88,538			14,725		103,263
Selling, general, and administrative expenses		50,579			12,129		62,708			52,393			13,495		65,888
Operating income		37,666			721		38,387			36,145			1,230		37,375
Interest expense, net		8,029			-		8,029			10,340			-		10,340
Investment loss		8,879			-		8,879			6,149			-		6,149
Gain on extinguishment of debt		(1,377	)		-		(1,377	)		-			-		-
Income before income taxes		22,135			721		22,856			19,656			1,230		20,886
Income tax expense		5,623			183		5,806			4,620			289		4,909
Consolidated net income		16,512			538		17,050			15,036			941		15,977
Net loss attributable to non-controlling interest		(472	)		-		(472	)		(445	)		-		(445	)
Net income attributable to Turning Point Brands, Inc.	$	16,984		$	538	$	17,522		$	15,481		$	941	$	16,422

Period	Total Number of Shares Purchased ⁽¹⁾		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
April 1 to April 30		4,431	$	23.65		-	$	27,197,886
May 1 to May 31		-	$	-		-	$	27,197,886
June 1 to June 30		-	$	-		-	$	27,197,886
Total		4,431				-

Exhibit No.	Description

10.1	~~Amendment No 1. Dated as of May 10, 2023, to~~Employment Agreement by and between the ~~Credit Agreement,~~Company and Andrew Flynn, dated as of ~~February 11, 2021, by and among Turning Point Brands, Inc., the obligors party thereto, Barclays Bank PLC, as administrative agent, and the lenders party thereto~~March 6, 2024 (incorporated herein by reference to Exhibit 10.1 of Turning Point ~~Brand,~~Brands, Inc’s Current Report on Form 8-K filed with the Commission on ~~May 16, 2023~~March 12, 2024 (File No. 001-37763)).

10.2	Employment Agreement by and between the Company and David Glazek, dated as of March 29, 2024.*

31.1	Rule 13a-14(a)/15d-14(a) Certification of Graham Purdy.*

31.2	Rule 13a-14(a)/15d-14(a) Certification of ~~Luis Reformina.~~Andrew Flynn.*

31.3	Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*

32.1	Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

~~99.1~~	Notice of Pendency of Settlement of Action *

101	XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended ~~June 30, 2023,~~March 31, 2024, filed on ~~August~~May 2, ~~2023,~~2024, formatted in Inline XBRL (iXBRL): (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to consolidated financial statements.*

104	Cover Page Interactive Data File (formatted in iXBRL and included in Exhibit 101).*


		By: /s/ ~~Luis Reformina~~Andrew Flynn
		Name: ~~Luis Reformina~~Andrew Flynn

		Title: Chief Accounting Officer

Date: ~~August~~May 2, ~~2023~~2024